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ABSTRACT 
The purpose of this dissertation was to examine the effect of dietary camitine 
supplementation on ethanol and fatty acid metabolism. Rats · were fed purina chow as 
such (non-supplemented, NS) or supplemented with 0.5% L-carnitine (camitine 
supplemented, CS). Carnitine supplementation for 7d resulted in decreased oxidation 
of an oral dose of [ l-14C]-ethanol. Expired 14C02 was significantly reduced at hours 4-
12 in the CS group. There were no significant differences in urinary excretion of the 
14C-label between the two groups which accounted for only about 3% of the total dose. 
The 14C-label rem�ning in tissues after 12h was also. not significantly affected by 
camitine supplementation. Blood-ethanol concentrations (BEC) were 88.5 and 125.9 
mg/dl in the NS and CS groups, respectively, 3h post-ethanol administration (PEA). 
Liver-ethanol concentrations· (LEC) were 1.70 and 0.85 µg/mg in the NS and CS 
groups, respectively 3h PEA. Examination of liver concentrations of pyruvate, lactate, 
acetoacetate, and 3-hydroxybutyrate i:evealed no significant difference� between the NS 
and CS groups. Plasma. concentrations of lactate were 2-fold higher in the CS group, 
but pyruvate, acetoacetate and 3-hydroxybutyrate were not significantly different 
between the two groups. Plasma and liver non-esterified camitine (NEC), acid soluble 
acylcarnitine (ASAC) and acid insoluble acylcarnitine (AIAC) concentrations were all 
significantly higher in the CS group 3h after ethanol administration. The effect of 
camitine supplementation on the urinary excretio� of ethanol, its metabolites and 
camitine was determined by feeding rats the NS and CS diets for 7 d. The rats were 
then given an oral dose of [ l-14C]-ethanol and urine was collected for the next twenty 
iv 
four hours. Food intake, water intake and urine volume were not significantly 
different between the NS & CS groups over the 24h period. Urinary excretion of 
ethanol and the 14C-label were not significantly affected by carnitine supplementation. 
Urinary excretion non-esterified carnitine (NEC), acid-soluble acyl-carnitine (ASAC) 
and acid-insoluble acyl-camitine (AIAC) were significantly elevated in the CS group 
over the 24h period. Supplementary carnitine did not significantly affect the oxidation 
of [14C(U)]-palmitate. There were no significant differences between the NS and CS 
groups with regard to the rates of 14C02 appearance or percent of the dose following 5, 
10, 20, 30 & 40 days of feeding CS diet. Ethanol administration resulted in decre·ased 
palmitate oxidation, at hours 4-24, but dietary carnitine supplementation did not affect 
the decreased oxidation due to ethanol. 
V 
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CHAPTER I 
INTRODUCTION 
One of the most prominent metabolic effects of ethanol consumption is the 
disturbance in lipid metabolism leading to hepatic steatosis. As with most clinical 
disorders the actual mechanism(s) leading to a fatty liver are not well understood and 
are probably the result of a combination of factors. Several potential mechanisms 
responsible for the accumulation of lipids in the ethanol-compromised liver �ave been 
discussed by Baraona and Lieber (1); for example, increased supply of lipids from the 
small intestine, increased uptake of fatty acids by the liver, increased mobilization of 
fatty acids from adipose tissue, increased synthesis of fatty acids in the liver, increased 
esterification of fatty acids in the liver, decreased oxidation of fatty acids in the liver, 
decreased hydrolysis of fatty acid esters in the liver, decreased excretion of liver fat 
into the bile, and decreased release of serum lipoproteins. It is obvious there is no 
clear solution to the steatogenic effect of ethanol on the liver, but the most probable 
explanation is that ethanol inhibits fatty acid oxidation and promotes fatty acid 
synthesis and elongation resulting in an increased supply of long-chain fatty acids. 
available for esterification to glycerol. 
Ethanol oxidation occurs primarily in the liver (2-4). It is first oxidized to 
acetaldehyde by one of three enzyme systems; alcohol dehydrogenase (ADH), catalase 
or the microsomal ethanol oxidizing system (MEOS) (5-7). ADH is located in the 
cytosol and catalyzes the major pathway of ethanol oxidation. However, MEOS is 
known to contribute significantly to ethanol oxidation· following chronic or high doses 
of ethanol (8). Acetaldehyde is subsequently oxidized to acetate in the mitochondrial 
matrix by aldehyde dehydrogenase 
(5, 7, 9). Both dehydrogenase-catalyzed reactions are coupled to the reduction of 
NAO+ to NADH. This results in an increase in the NADH/NAD+ ratio in both the 
cytosol and the mitochondrial matrix of the hepatocyte ( 10, 11). The excess in 
reducing equivalents will result in inhibition of glycolysis, the TCA cycle and fatty 
acid oxidation and promote fatty acid synthesis and esterification (individual reactions 
will be discussed in the review of literature). The acetate generated from ethanol 
oxidation has the potential to be incorporated into fatty acids, which would further 
promote the lipogenic effect of ethanol. Thus ethanol oxidation has a possible three­
fold effect on lipid metabolism in the liver by (1) decreasing fatty acid oxidation, (2) 
enhancing the synthesis of fatty acids and (3) increasing fatty acid incorporation into 
triglycerides. 
Alcoholic fatty liver and hyperlipidemia are often associated with more serious 
diseases such as hepatitis, liver cirrhosis, and atherosclerosis ( 1). This has prompted 
attempts to ameliorate ethanol-induced hepatic steatosis. Supplementation of a liquid 
ethanol diet with D,L-carnitine results in decreased concentrations of lipids, especially 
triglycerides, in the liver ( 12, 13). There are several possible mechanisms by which 
carnitine may have a lipid lowering effect in the liver. All of these mechanisms 
involve the increased availability of carnitine, due to supplementation, to serve as a 
substrate for carnitine acyl-transferase. The possible mechanisms are: 
2 
3 
1. Increased levels of free carnitine could accommodate the inpux of fatty acids by 
serving as a co-substrate for carnitine acyl-transferase. This would result in 
higher concentrations of acyl-carnitines which may enhance the activity of 
carnitine acylcarnitine translocase and facilitate the transport of acyl-carnitine 
into the mitochondrial matrix. The higher concentrations of fatty acids inside the 
matrix may then promote P-oxidation. 
2. The carnitine-induced increase in carnitine acyl-transferase activity would 
compete with glycerol-phosphate acyl-transferase for acyl-CoA 's. This could 
result in decreased formation of phosphatidate, a substrate for synthesis of 
. triglycerides and phosphoglycerides. Carnitine acyl-transferase would also 
compete for acyl-CoA's needed to synthesize triglycerides from diglycerides. 
The net effect would be a decrease in triglyceride synthesis resulting from the 
esterification of acyl groups to carnitine rather than to the glycerol. 
3 .  There may also be increased activity of carnitine acetyl-transferase which would 
compete with acetyl-CoA carboxylase for acetyl CoA units. This may reduce the 
amount of malonyl CoA available for fatty acid synthesis. 
4 .  In each of the above situations there is increased formation of acyl-carnitine . 
. The acyl-carnitines can enter the blood stream and be distributed in the extra­
hepatic organs or excreted in the urine. Thus, removal of the fatty acids as acyl­
carnitines from the liver pool should result in less of a burden on the liver due to 
alcohol. 
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Another related effect of dietary camitine supplementation is the elevated blood 
ethanol concentrations following both acute and chronic doses of ethanol (14, 15). It 
is generally agreed that the redox state of the hepatocyte is rate controlling for ethanol 
oxidation (2-4). Excess cytosolic NADH generated via ADH will inhibit the 
dissociation of the ADH-NADH complex, which is the rate limiting step in ethanol 
oxidation (4-6). If carnitine doe� increased '3-oxidation, it would provide reducing 
equivalents and produce acetyl-CoA. Both of which would have the potential to 
inhibit ethanol oxidation and result in higher blood ethanol concentrations. 
The objective of this dissertation was to examinC? the possible mechanisms 
responsible for th� lipotropic effect of carnitine on ethanol-induced fatty liver, its 
effect on ethanol oxidation and the possible relationship of the two effects. The 
mechanisms were investigated by the following courses of action. 
1. The effect of dietary camitine on ethanol oxidation was determined by measuring 
the oxidation of [ l-14C]-ethanol to 14C02 along with the effect of carnitine on the 
redox _state which �as determined by measuring lactate/pyruvate and �­
hydroxybutyrate/acetoacetate ratios in the liver and blood. 
2. The effect of dietary carnitine supplementation on P-oxidation was determined by 
measuring the oxidation of [14C(U)]-palmitate to 14C02 with and without ethanol 
administration. 
3. The effect of dietary camitine on urinary excretion of ethanol, its metabolites, 
and acyl-camitines was determined by measuring the concentration of ethanol, its 
metabolites and acyl-carnitines in the urine following [ l- 14C]-ethanol 
administration. 
5 
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CHAPTER II 
REVIEW OF LITERATURE 
ETHANOL METABOLISM 
Ethanol is readily absorbed from the gastro-intestinal tract (3). Gastric 
absorption accounts for about 20% of ethanol absorption with the remainder being 
absorbed by the small intestine (16). After absorption ethanol is evenly distributed in 
body water (16) and accumulates in tissues with the highest water content ( 17). There 
is a general consensus that the liver is responsible for the majority of ethanol 
metabolism. Hepatic oxidation accounts for around 75% of the metabolism of ethanol· 
as demonstrated by liver perfusion (18 ,  19), hepatic vein catherization (20), ethanol 
infusions (2 1), partial (22) and complete hepatectomy (23), and evisceration (23). The 
remainder of ethanol is metabolized extra hepatically or eliminated through the 
kidneys and lungs (2-10%) (3). 
Ethanol is first oxidized to acetaldehyde via either alcohol dehydrogenase (ADH, 
reaction a), the microsomal ethanol oxidizing (MEOS, reaction b) or catalase (reaction 
c). 
(a) CH3CH20H + NAD+ �> CH3CHO + NADH + H+ 
(b) CH3C�OH + NADPH + H+ + 02 MF.Os > CH3CHO + NADp+ 
(c) CH3CH20H + H202 • CATALAsE> CH3CHO + 2H20 
ADH catalyzes the oxidation of ethanol to acetaldehyde coupled to the reduction 
of NAD+ to NADH. ADH occurs at highest concentrations (> 90% of total ADH 
activity) in the liver where it is found in the cytosol (2-7). Mammalian alcohol 
dehydrogenases are polymorphic and the isozymes can be classified based on their 
function and lphysicochemical properties (24-26). The enzyme responsible for ethanol 
oxidation in rat liver is isozyme ADH III. It has a Km of 1.4 mM for ethanol and Ki 
of 10.4 mM for pyrazole (24). All evidence indicates that ADH is the principle 
enzyme responsible for the oxidation of ethanol (2-5). Studies using the ADH 
inhibitors pyrazole and 4-methylpyrazole, result in a 85-90% inhibition of ethanol 
metabolism in vivo (27). The rate limiting step, in vitro, in the ADH catalyzed 
reaction is the dissociation of the ADH-NADH complex (4, 10). This most likely is 
responsible for the rate limiting step in ethanol oxidation, in vivo, which is the re­
oxidation of NADH (which will be discussed later) (10). 
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The observance that chronic alcohol administration results in the proliferation of 
hepatic smooth endoplasmic reticulum led to the speculation that it may be involved in 
ethanol oxidation (28). It was later demonstrated than an ethanol-oxidizing system 
could be reconstituted with cytochrome P-450, NADPH-Cytochrome C-reductase, and 
phospholipids (29). Most recently, a 52,000 dalton polypeptide, termed P450IIEI (also 
P-450), has been purified by immunoelectrophoresis and shown to be inducible by 
ethanol. Like other cytochrome P-450 - dependent monooxygenases, MEOS requires 
oxygen and NADPH. The number one carbon of ethanol is hydroxylated in a 
cytochrome P-450 dependent manner with the concomitant oxidation of N ADPH. The 
doubly hydroxylated carbon is unstable and -water splits-out leaving acetaldehyde. 
Historically, the role of MEOS in ethanol metabolism has been controversial. The 
8 
contribution of MEOS to total ethanol oxidation increases with chronic abuse and high 
doses of ethanol (8 , 31). Since MEOS utilizes NADPH and the NADP/NADPH and 
NAD/NADH systems are linked, ethanol oxidation via MEOS co':1ld result not on�y in 
accelerated ethanol metabolism because of MEOS activity, but it may also accelerate 
the ADH pathway by favoring the re-oxidation of NADH (11). The theory for the 
increased MEOS activity at higher ethanol concentrations is that the Km for ethanol 
by ADH is around 2 mM and the Km for ethanol by the MEOS is around 10 mM. So 
at low concentrations of ethanol (10 mM) ADH is already saturated and at higher 
ethanol concentrations the MEOS has the ability to oxidize more ethanol. 
Catalase is a peroxisomal enzyme that can catalyze the peroxidative cleavage of 
· ethanol to acetaldehyde in the presence of a H202 generating system. It is generally 
accepted that the H202 - mediated ethanol peroxidation by catalase is limited by the 
rate of H202 generation. Since the physiological rate of H202 production is rather low, 
the contribution of catalase to in vivo ethanol elimination is not quantitatively 
significant (2, 3 ,  26). 
Regardless of the pathway of the oxidation of ethanol to acetaldehyde the next 
step in the complete oxidation of ethanol is the oxidation of acetaldehyde to acetate 
catalyzed by aldehyde dehydrogenase (ALDH). The overall reaction is: 
CH3CH\0 + NAD+ + H20 AIDH > CH3CHOOH + NADH + H+ 
The reaction is essentially non-reversible with a i\G = -13 kcal/mole and is 
responsible for the rapid removal of acetaldehyde ( 4 ). Rat liver contains several 
ALDH isozymes (9). The isozyme responsible for acetaldehyde oxidation is localized 
9 
in the mitochondrial matrix as a soluble protein and has a Km of 0. 7 mM for 
acetaldehyde (9). 
Most reviews state that ethanol and acetaldehyde are metabolized primarily in the 
liver and acetate is disposed of in the extrahepatic tissues (1-4). This could be 
misleading and downplay the role of the liver in acetate metabolism. Studies using 
liver perfusion, liver slices and hepatocytes find that 14C-ethanol is partially recovered 
as 14C02 and TCA cycle intermediates (32-39), indicating further oxidation of acetate 
in the liver. The incorporation of 14C-ethanol into acetoacetate, (3-hydroxybutyrate, 
triglycerides and cholesterol indicate� that the liver is .involved in the utilization of 
acetate for the synthesis of these compounds (35-38 ). Also, in vivo, the acetate 
�eleased into the blood no doubt is re-circulated through the liver and would be 
available for re-entry into the· hepatocyte. 
When ethanol is oxidized to acetaldehyde in the cytoplasm via ADH, there is a 
stoichiometric reduction of NAD+. The mitochondrial membrane is impermeable to 
. . 
NADH. S� !educing eq�ivalents must be transferred into the mitochondria via the cx­
glycerophosphate or malate shuttle (4). NAD+ may also be regenerated in the cytosol 
by coupling NADH oxidation to reduction reactions (4). The oxidation of ethanol 
exceeds the hepatocyte's ability to utilize the reducing equivalents resulting in an 
increased NADH\NAD+ ratio (10, 1 1). It _is this decreased ratio which is responsible 
for many of the deleterious effects of ethanol. 
10 
DEVELOPMENT OF FATTY LIVER 
· The accumulation of lipids in the ethanol compromised liver can originate from 
three main sources: dietary lipids, adipose tissue lipids and endogenous synthesis by 
the liver. The source of the lipids varies with the type of ethanol administration. The 
administration of a single large dose of ethanol leads to hepatic accumulation of fatty 
acids resembling those of adipose tissue. In contrast, prolonged ethanol ingestion 
produces fatty livers consisting of endogenously synthesized fatty acids and dietary 
fatty acids (40, 43). The proposed theory for the difference is that the large acute 
dose represents a stressful situation to the rat causing the release of catecholamines. 
So through �-adrenergic stimulation, lipase is activated resulting in the hydrolysis of 
triglycerides and the release of fatty acids from adipose tissue (1). · Chronic 
administration, as the liquid ethanol diet, represents a less stressful situation and fatty 
acid turnover is more representative of "normal" metabolism. It has also been 
demonstrated that the degree of triglyceride accumulation in the liver varies with 
increasing amounts of fat in the diet and with increasing chain length of fatty acids in 
the diet ( 44, 45). 
Although there are several potential mechanisms for the accumulation of fat in 
the ethanol-compromised liver the most likely candidates are decreased �-oxidation, 
. . 
increased synthesis of triglycerides and increased synthesis and elongation of fatty 
acids. All three can be at least partially explained by the change in the redox state 
and excess acetate formed during ethanol oxidation. 
1 1  
There is considerable evidence that ethanol does inhibit the oxidation of fatty 
acids. In humans, the formation of 14C02 from 14C-oleic acid was reduced and the 
effect was partially abolished by 4-methylpyrazole (46). The addition of ethanol to 
human and rat liver slices reduces 14C02 from 14C-labeled oleic acid, palmitate and 
linoleic acid and the addition of 4-methylpyrazole inhibited the effect (47). The above · 
results do not prove that �-oxidation is inhibited since the inhibition of 14C-fatty acid 
to 14C02 could result from TCA cycle inhibition. However, ethanol was later shown 
to decrease· formation of ketone bodies ( 48 ), acetyl-CoA ( 49) and CO2 ( 48 ,  49) from 
labeled fatty acids, thus confirming the decrease in P-oxidation due to ethanol. 
The common feature to all the above experiments is that the effects of ethanol on 
fatty acid oxidation were decreased considerably when ethanol metabolism via ADH 
was inhibited by 4-methylpyrazole. In fact, pyrazole titration experiments demonstrate 
a correlation between changes in the mitochondrial NADH/NAD ratio and both 
inhibition of the TCA cycle and inhibition of the �-oxidation pathway (49). The TCA 
cycle is sensitive to inhibition by N ADH at isocitrate dehydrogenase and at 
ketoglutarate dehydrogenase steps (49). P-oxidation would be r�stricted at �­
hydroxyacyl-COA dehydrogenase and acyl-CoA dehydrogenase ( 1 ). Ethanol also 
influences the activity of carnitine palmitoyltransferase I (CPT-1). In hepatocytes 
isolated from rats fed a liquid ethanol diet CPT-1 activity was markedly decreased and 
its sensinvity to inhibition by exogenously added malonyl-C.9,A was increased (50). -
Pre-incubation of hepatocytes from rats fed control diets with ethanol or acetaldehyde 
also decreased CPT-I activity and increased sensitivity to malonyl-CoA (50, 5 1). 
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CPT-I is generally considered to catalyz.e the rate limiting step in the transport of long 
chain fatty acids into the mitochondrial matrix (50). 
The effect of ethanol on fatty acid synthesis remains unsettl�d. The incubation 
of hepatocytes, isolated from rats given an acute dose of ethanol, with either 14C­
ethanol or 14C-acetate resulted in increased incorporation of the label into fatty acids 
(52). Perfusion of isolated rat liver demonstrated that ethanol directly enhanced the 
synthesis of fatty acid from labeled acetate (53). However, rats fed the liquid ethanol 
diet failed to show an increase in the incorporation of 3H20 into fatty acids but did 
show an increase in triglycerides in the liver (55-57). Although it seems probable that 
the liver would increase fatty acid synthesis in order to cope with the excess NADH 
and acetate; conflicting data do not entirely support the theory. 
The increase in lipid content in the ethanol-induced liver is mostly due to the 
increase in triglyceride content. Ethanol administration results in enhanced 
incorporation of 14C-palmitate into triglycerides in hepatocytes (47, 48). Rats fed a 
liquid ethanol diet incorporate more 14C-glycerol into triglycerides than control animals 
(54). Isolated perfused livers incorporate more 14C-acetate into triglycerides in the 
presence of ethanol (53). There is a rapid increase of the a-glycerophosphate content 
of the liver after ethanol administration (58). The proposed mechanism is the 
increased concentration of NADH will increase the production of a-glycerophosphate 
from dihydroxyacetone phosphate (58). Thus with increased levels of fatty acids 
(froni decreased oxidation and possibly increased synthesis) and higher conce�trations 
of a-glycerophosphate, conditions are favorable for triglyceride synthesis. 
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CARNITINE AND ETHANOL METABOLISM 
Camitine serves as an esse�tial carrier for long chain acyl groups across the 
mitochondri� membrane to sites of oxidation. It was this role of camitine that first 
prompted investigators to examine the possibility that camitine might help prevent the 
alcohol-induced fatty liver. The addition of camitine to the ethanol solution in rats 
orally receiving a dose of 6g ethanol/kg b.w. resulted in significantly lower 
concentrations of triglycerides in the liver and blood 24h after ethanol administration 
(59). The addition of camitine to a diet (containing 36% calories as ethanol) fed to 
rats for 56d resulted in significantly lowered levels of total lipids, free and esterified 
cholesterol, triglycerides and phospholipids 1n the liver (12). The effect was later 
· found to be dose dependent up to 0.8% DL-camitine (13). Dietary carnitine 
supplementation of the liquid ethanol diet results in elevated blood-ethanol 
concentrations (BEC) ( 14 ). Carnitine supplementation has also resulted in elevated 
BEC under acute ethanol administration (14, 15). Under both acute and chronic 
conditions carnitine administration has resulted in both decreased lipids in the liver 
and higher BEC. One possible explanation for the observations is that carnitine is 
causing increased �-oxidation of fatty acids which results in lower lipid levels. The 
increase in �-oxidation will result in an · increased intramitochondrial redox potential 
(E = Eo-2.3RT/nF log [RED]/[OX]) (61) which would inhibit regeneration of NAO+ 
from NADH and elevate BEC. Another possible mechanism for the lipid lowering 
effect of carnitine is that carnitine traps excess acetyl groups derived both from free 
14 
acetate, formed by ethanol oxidation, and from acetyl-CoA, accumulated as a result of 
the ethanol-induced decrease in the TCA cycle (61). 
CHAPTER Ill 
MATERIALS AND METHODS 
ANIMALS, HOUSING AND DIETS 
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Animals used in these studies were mature male Sprague-Dawley rats (Harlan 
Sprague-Dawley, Inc., Indianapolis, IN). They were kept in an ALAS accredited 
facility and individually housed in 7" X 10" X 7" wire mesh, stainless steel cages and 
kept in ventilated cubicles with glass sealing doors� The temperature in each cubicle 
was maintained at 72 .= 2°C, relative humidity between 40-50% with a cycle of 12. 
hours light and 12 hours dark. The rats were fed ground Purina Rat Cow #500 1 
(Ralston Purina, St. Louis, MO). The diets were fed as such (non-supplemented, NS) 
or supplemented with 0.5% (w/w) L-Camitine (camitine supplemented, CS). Camitine 
was supplemented as a hydro-chloride salt (Sigma, St. Louis, MO). All diets and 
water were supplied ad libitum. 
EXPERIMENT AL PROCEDURES 
Experiment 1 (l-14C]-Ethanol Oxidation 
The objective of this experiment was to determine the effect of dietary carnitine 
supplementation on [l-14C]- ethanol oxidation, distribution and urinary excretion. Ten 
rats (300-350g) were divided into 2 groups of 5 and fed Purina rat chow as such (non­
supplemented, NS) or supplemented with 0.5% (w/w) L-carnitine (camitine 
supplemented, CS) for 7d. 
[ l -14C]-ethanol (New England Nuclear, Boston, MA) was mixed with absolute 
ethanol and double distilled water to yield a 13% (v/v) solution containing 
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1 x 107dpm/� ethanol. The rats �rally received 3g ethanol/kg bwt and were placed in 
respiratory chambers. 14C02 was collected as descri�d later. After 12 h the animals 
were anesthetized with Metofane (Pitman-Moore, Washington Crossing, NJ) blood wa.s 
collected by cardiac puncture; liver, kidney, heart, semitendinusus leg muscle, 
epididymal fat pad, and brain were removed· and stored at -20°C. 
Experiment 2 Blood and Liver Ethanol Concentrations and Redox State 
The objective of this experiment was to determine the effect of dietary carnitine 
supplementation on the redox state of the liver following ethanol administration. Ten 
rats (300-350g) were divided into 2 groups of 5 and fed Purina rat chow as such (NS) 
or supplemented with 0.5% L-carnitine (CS) for 7d. 
[ l -14C]-ethanol (New England Nuclear, Boston, MA) was mixed with absolute 
ethanol and glass distilled water to yield a 13% v/v solution containing 1 X 107 dpm/g 
ethanol. 'The rats orally received 3g ethanol/kg bwt. Three hours later the rats were 
decapitated, blood was collected from. the neck and liver was r�moved .within 45 sec 
and dropped _in liquid ni�gen. Plasma and livers were stored at -7(1'C. 
Experiment 3 Urinary Excretion of [l-14CJ Ethanol 
The objective of this experiment was to determine the effect of dietary carnitfoe 
supplementation on urinary excretion of ethanol, its metabolites and camitine 
following ethanol administration. Ten rats (300-350g) were divided into 2 groups of 5 
and fed Purina rodent chow as such (NS) or suppl�mented with 0.5% L-carnitine (CS) 
for 10d. [ l -14C]-ethanol (New England Nuclear, Boston, MA) was mixed with 
absolute ethanol_ and double glass distilled water to yield a 13% (v/v) solution 
containing 1 x 107 dpm/g ethanol. The rats orally received 3 g ethanoVKg bwt and 
were placed in metabolic cages. Urine was collected for the next 24 hr. 
Experiment 4 (14C(U)J-Palmitate Oxidation Time Course 
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The objective of this experiment was to determine the effect of dietary carnitine 
supplementation on [14C(U)]-palmitate oxidation. Thirty rats (300-350 g) were divided 
into 5 groups of 6. One-half th� rats from each group received Purina rodent chow as 
such (NS) or supplemented with 0.5% L-carnitine (CS). The groups were fed their 
respective diets for 5, 10, 20, 30 and 40d. 
A 2.5% palmitate solution was prepared by adding 2.5 g palmitic acid to a 
mixture of 50 ml double distilled water and 0.25 ml of 4.0 N KOH. The mixture was 
then sonicated until homogeneous. The pH was adjusted to 7 .5 by the addition of 
concentrated HCI. It was necessary to slowly add HCl then sonicated in order to 
obtain accurate pH readings and to ensure homogeneity. Total volume was then 
brought to 100 ml with double distilled water. The final solution had the consistency 
of coconut milk. [14C(U)]-palmitate (New England Nuclear, Boston, MA) was mixed 
with freshly sonicated 2.5% palmitate to yield a solution containing 2 x 107 dpm/g 
palmitate. The rats orally received 0.5 g palmitate/kg bwt (this would amount to about 
one-half of the normal daily intake of palmitate) and were placed in respiratory 
chambers. 4C02 was collected as described later. After 24 h the animals were 
anesthetized with Metof ane (Pitman-Moore, Washington Crossing, NJ) blood was 
collected by cardiac puncture; liver, kidney, heart, semitendinusus leg muscle, 
epididymal fat pad, and brain were removed and stored at -20°C. 
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Experiment 5 [14C(U)J-Palmitate Oxidation With Ethanol 
The objective of this experiment was to determine the effect of dietary carnitine 
supplementation superimposed with a single oral dose of ethanol on (14C(U)]-palmitate 
oxidation. Ten rats (300-350g) were divided into 2 groups of 5 and fed Purina rodent 
chow as such (NS) or chow supplemented with 0.5% L-carnitine (CS) for 10d. 
(
14C(U)]-palmitate was administered as in experiment 3. The rats were then 
placed in a respiratory chamber for 2 h. Air inside the chamber was evacuated by 
�locking influent air and allowing a vacuum to form. This should have prevented any 
loss of expired air. The rats were then removed and given an oral dose (3g ethanol/kg 
bwt) of 13% ethanol and returned to the respiratory chambers. 14C02 was determined · 
as described later. After 24 h the animals were anesthetized with Metofane (Pitman­
Moore, Washington Crossing, NJ) blood was collected by cardiac puncture; liver, 
kidney, heart, semitendinosus leg muscle, epididymal fat pad, �nd brain were removed 
and stored at -2D°C. 
ANALYTICAL PROCEDURES 
14C02 Analysis 
After receiving the labelled dose of either palmitate of ethanol the rats were 
placed into a respiratory chamber (Fig. 1). Air flowing into the chamber at l .OUmin 
(monitored by flow meter), first passed through a CO2 trap (Baralyme, Allied 
Healthcare Products, St Louis, MO) and a moisture trap (Molecular sieve 5A with 
Indicating Drierite, American Scientific Products, McGraw Park, IL). Effluent air 
from the metabolic chamber entered another moisture trap and was bubbled through 
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800 ml of 1.0 M KOH, then into a second CO2 trap containing 350 ml of 1.0 M KOH 
(virtually all the radioactivity was found in the first trap). 1.0 ml samples of the KOH 
solution were removed and mixed with 2.0 ml water and 15 ml of Aquasol II LSC 
cocktail (New England Nuclear, Boston, MA) in a scintillation vial; these were 
allowed to sit overnight, then. counted in a Beckman LS 380 1 Liquid Scintillation 
Counter. 
14C Determination in Tissues 
Approximately 100 mg of tissue was added to 1.0 ml 2.0 M Methanolic-KOH 
and digested at 60°C for 1 hr in a tightly · capped glass scintillation vial. The samples 
were _ then cooled to -20°C for 20 min. and 0.4 ml of glacial acetic acid was added 
followed by 15 ml of Aquasol II (New England Nuclear, Boston, MA). The vials 
were then placed in the dark overnight to reduce additional background counts due to 
chemilumesence. The next morning the vials were shaken, and counted in a Beckman 
Model 13801  Liquid Scintillation Counter. A blank for each specific tissue from rats 
not receiving labelled compounds was ran to determine the contribution of color to 
background DPM and was found to be negligible. Plasma and urine samples (0.2 to 
1.0 ml) were counted with or without KOH digestton and the KOH digestion did not 
alter the DPM. 
Sampling of Tail Vein Blood 
The dorsal tail vein was cut by making an incision directly over the vein and 
blood was collected in a 20 pl capacity, heparinized micro-hematocrit capillary tube. 
The contents of the tube were immediately delivered into a 1.5 ml capacity microfuge 
tube containing 980 µl of cold normal saline, capped and mixed well. The tube was 
then centrifuged at 1500 x g for 10 min at 2°c and kept on ice until ethanol 
concentration was determined within 24 hours (usually on the day of collection). 
Tissue Homogenation for Total Lipids, Triglycerides, and Carnitine 
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Approximately 1.0 g of tissue was added to 2 volumes of 1. 15% KCl containing 
0.01 M NaJIPOJKH�4 buffer (pH 7.4) and homogenized by four strokes in 
teflon/glass homogenizer. The top of the teflon plunger was then rinsed with 1 
volume of KCl solution and homogenize further by 2 more strokes. The homogenate 
was then poured into a graduated conical tube and th� homogenizer was rinsed with 1 
volume of KCl solution and added to the homogenate. This yielded a w/v 
homogenate. The homogenate was stored at 
-7CfC in 1 ml portions to avoid repeated thawings of the sample. 
Tissue Homogenation for Pyruvate, Lactate, Acetoacetate, 3-Hydroxybutyrate and 
Ethanol 
Froze� . livers were pulverized into a fine power by mortar and pestle. Liquid 
nitrogen was constantly poured into the mortar to prevent the liver from thawing. 
Approximately 100 mg of powdered liver, 200 µl plasma or 100 µl urine + 100 µl 
10% BSA were added to pre-weighed conical tubes containing 300 µl of 3.0 M HC104 
and 1.25 ml of qouble distilled water. The tubes were vortexed vigorously for 30 
seconds and allowed to sit in an ice water bath for 5 minutes, vortexed again and 
centrifuged for 10 minutes at 1500 x g at 2°C. 1.0 ml of the supernatant was removed 
and added to another conical tube on ice. The original tube was then allowed to wann 
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to room temperature and weighed. 200 pl of 3 M KHC03 was added and allowed to 
sit for 15 min., then centrifuged for 10 min at 1500 x g at 2°C. The supernatant was 
then poured off. Acetoacetate, pyruvate, and ethanol were assayed immediately. 
Lactate and 3-Hydroxybutyrate were assayed within 2 hours. 
Pyruvate Determination 
Pyruvate was determined fluorimetrically by the method of Passonneau & Lowry 
(62). The decrease in NADH concentration was measured by the decrease in 
florescence as pyruvate was reduced to lactate by bovine heart lactate dehydrogenase. 
Reagents 
1 .  1 .0 M :KiHPOJNaHJ>()4 (pH 7.0): 
Dissolve 2 1 .Sg K2HP04 and 19.0g NaH2P04 2H20 in 200 ml of double distilled 
water adjust pH to 7 .0 as necessary with 4.0 M KOH and bring up to 250 ml wi�h 
double distilled water. Store at 4°C. 
2. 5mM NADH: 
Dissolve 3.5 mg B-NADH-N3i, Grade m from yeast (Sigma, St. Louis, MO) per 
ml carbonate buffer. Heat to 60°C for 15 min and store at -20°C. Make fresh 
weekly. 
3. O. lM N3iCOJ.NaHC03 (pHl0.6): 
Dissolve 0.85g N3iC03 and 0. 17 g NaHC03 in 7.5 ml double distilled water adjust 
pH as necessary with 4.0 M KOH and bring up to 100 ml with double distilled 
water. Store at -200C. 
4.  20 mM Tris Buffer (pH 8 .0): 
Dissolve 0.24 g Tris (Sigma, St. Louis, MO) in 75 ml of double distilled water, 
adjust pH to 8 .0 with 1.0 M HCl, add 200 pl 10% BSA and bring to 100 ml. 
Store at -2D°C 
5. Lactate Dehydrogenase (LDH): 
Dilute stock LDH, Bovine Heart Type III in 2.1 M �)2S04 (Sigma, St. Louis, 
MO) with 20mM Tris to yield 500 u/ml. Make fresh daily. 
6. 1.0 mM Pyruvate: 
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Dissolve 18 .3 mg Pyruvic Acid-potassium salt Type m (Sigma, ST. Louis, MO) 
per ml double distilled water. This yields a 0.1 M solution. Dilute to 1.0 mM by · 
adding 100 pl to 9.9 ml double distilled water. Make fresh daily. 
7. 3 .0 M HC104: 
Dilute 25 ml 70% HC104 to 100 ml with double distilled water. Store at 4°C. 
8 .  Reagent Mixture: 
Add 10 ml 1.0 M phosphate buffer and 100 pl of 5mM NADH to 90 ml double 
distilled water. Prepare fresh daily. 
9. 10% BSA: 
Dissolve 10g BSA in 75 ml double distilled water and bring to 100 ml with 
double distilled water. 
10. 3 .0 M KHC03 : 
Dissolve 30 g KHC03 in double distilled water and make up to 100 ml. Store at -
2Q°C. 
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Procedure 
A standard curve was prepared by adding 0, 10, 20, 40, 60, 80 and 100 µl (Fig. 2) 
of pyruvate standard to tubes containing 100 µl 10% BSA, 300 µl of 3 .0 M HC104 and 
double distilled water to a total volume of 1.65 ml. The tubes were vortexed 
vigorously for 30 sec and allowed to sit in an ice water bath for 5 min, vortexed again 
and centrifuged for 10 min at 1500 x g at 2°C. 1.0 ml of the supernatant was removed 
and added to another conical tube on ice. 200 µl of 3M KHC03 were added and 
allowed to sit for 15 min, then centrifuged for 10 min at 1500 x g at 2°C. The 
supernatant was then poured off into another tube on ice. A 100 µl aliquqt of the 
neutralized standard or tissue supernatant was added to 1.9 ml of reaction mixture in a 
4.5 ml polystyrene Ultra-Vu disposable cuvette (Baxter Scientific Products, Atlanta, 
GA) and mixed by inversion. Baseline florescence was determined in a Hitachi F-
2000 Florescence Spectrophotometer (Exitation 360 and Emission 460 um). 20 µl of 
LDH (approx. IOU) was then added. The cuvettes were mixed by inversion and let sit 
at room temperature for 30 min �n the dark. After 30 min florescence was determined 
again. The decrease in florescence was proportional to the concentration of pyruvate. 
Calculations 
Florescence X 1/slope X 5 = nmoles/ml plasma or urine 
Florescence X 1/slope + mg liver = nmoles/mg liver 
Florescence X 1/slope + 10 = nmoles/ml/nmoles/ml urine 
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Figure 2. Pyruvate Standard Curve 
Lactate Determination 
Lactate was determined by the method of Passonneau (63). The increase in 
NADH concentration was measured by the increase in fluorescence as lactate is 
oxidized to pyruvate by bovine heart lactate dehydrogenase. 
Reagents 
1. 2-Amino-2-methyl-1-propanol buffer (1 M; pH 10.0): 
Dissolve 8.9 g 2-amino-2-methyl-1-propanol (9.5 ml if liquid) in double distilled 
water, adjust pH to 10.0 with 12 M HCl and dilute to 100 ml. with 
double distilled water. Store at -2D°C. 
2. Tris buffer (20 mM; pH 8.0): 
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Dissolve 0.24 g Tris (Sigma, St. Louis, MO) in double distilled water adjust pH to 
8 with 1.0 m HCL add 200 pl 10% BSA and dilute with double distilled water to 
100 ml. Store at -2D°C. 
3 .  Hydrazine Hydrate, (Sigma, St. L<?uis, MO) 
4. Nicotin�de-adenin� dinucleotide (0. 1 M B-NAD Grade III) from yeast (Sigma, 
St. Louis, MO). 
Dissolve 70 mg. NAD in 1 ml double distilled water. Store frozen. 
5. Lactate dehydrogenase, LDH 
Dilute stock LDH, Bovine heart Type III in 2. 1 M (NH4)2S04 (Sigma, St. Louis, 
MO) with 20 mm Tris to yield 500 u/ml. 
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6. 1.0 mM Lactate 
Diss�lve 10.3 mg L (+)-Lactic Acid-Lithium salt Grade L-X (Sigma, St. Louis, 
MO) per' ml double distilled water this yields a 0.1 M solution. Dilute to 1.0 mM 
by adding 100 µl to 9 .9 ml double distilled water. Make fresh daily. 
7. Perchloric acid (3 M): 
Dilute 25 ml. 70% HC104 with double distilled water to 100 ml. 
8. Potassium hydrogen carbonate (3 M): 
Dissolve 30 g. KHC03 with double distilled water and make up to 100 ml. 
9.  Reagent mixture 
Mix 10.0 ml buffer solution (1), 250 µl Hydrazine Hydrate and 50 µl NAD and 
bring to 100 ml with double distilled water. 
Procedure 
A standard curve was prepared by adding 0, 10, 20, 40, 60, 80 and 100 µl (Fig. 3) 
of lactate standard to tubes containing 100 µl 3 .0 M HC104 and double distilled water 
to a total volume of 1.65 ml. The tubes were vortexed vigorously for 30 sec and 
allowed to sit in an ice water bath for 5 min vortexed again and centrifuged for 10 
min at 1500 X g at 2°C. 1.0 ml of the supernatant was removed and added to another 
conical tube on ice. 200 µl of 3 M KHC03 were added and allowed to sit for 15 min, 
then centrifuged for 10 min at 1500 x g at 2°C. The supernatant was then poured off 
into another tube on ice. A 100 µl aliquot of the neutralized standard or tissue 
supernatant was added to 1.9 ml of reaction mixture in a 4.5 ml polystyrene Ultra-Vu 
disposable cuvette (Baxter Scientific Products, Atlanta, GA) and mixed by inversion. 
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Figure 3. Lacta� Standard Curve 
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Baseline florescence was determined in a Hitachi F-2000 Fluorescence 
Spectrophotometer (Exitation 360 and Emission 460nm). 10 µl of LOH was then 
added, the cuvettes were mixed by inversion and let sit at room temperature for 30 
min in the dark. After 30 min fluorescence was determined again. The increase in 
florescence was proportional to the concentration of lactate 
Calculations 
Fluorescence X I/slope X 5 = nmoles/ml plasma 
Fluorescence X I/slope + mg liver = nmoles/mg liver 
Fluorescence X I/slope x 10 = nmoles/ml urine 
Acetoacetate Determination 
Acetoacetate was determined by the method of Mellanby and Williamson ( 64) 
adapted from spectrophotometry to fluorescent spectrophotometry. The decrease in 
NADH concentration was measured by the decrease in fluorescence as acetoacetate 
was reduced to 3-Hydroxybutyrate. 
Reagents 
1. I .OM K2HPOJNaH2P04 (pH 7.0): 
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Dissolve 21.8 g KiHP{)4 and 19.0g NaH2P04 2H20 in 200 ml of double 
distilled water adjust pH to 7 .0 as necessary with 4.0MKOH and bring up to 250 
ml with double distilled water. Store at 4°C. 
2. 5mM NADH: 
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Dissolve 3 .5 mg B-NADH-N�, Grade III from yeast (Sigma, St. louis, MO) per 
ml of carbonate buffer. Heat to 60°C for 15 min and store at -2D°C. Make fresh 
weekly. 
3 .  0.1 M N�COJNaHC03 (pH 10.6): 
Dissolve 0.85g N�C03 and 0.17g NaHC03 in 75 ml double distilled water adjust 
pH as necessary with 4.0 MKOH and bring up to 100 ml with double distilled 
water. Store at -2Q°C. 
· 4. 20mM Tris Buffer (pH 8 .0): 
. Dissolve 0.24g Tris (Sigma, St. Louis, MO) in 75 ml of double distilled water 
adjust pH to 8 .0 with I.OM HCl add 200 µl 10% BSA and bring to 100 ml. 
Store at -2Q°C. 
5.  3-Hydroxybutyrate Dehydrogenase. Type II from Rhodopseudomonas spheroides 
in 3 .2M (NH,.)2So4 (Sigma, St. Louis, MO). 
6. l .OmM Acetoacetate 
Dissolve 1 1 .5 mg Acetoacetic Acid-Lithium Salt (Sigma, St. Louis, MO) per ml 
double distilled water. This yields a OllM solution. Dilute to 1.0mM by adding 
100 µl to 9.9 ml double distilled water. 
7. 3 .0M HC104: 
Dilute 25 ml 70% HC104 to 100 ml with double distilled water. Store at 4°C. 
8� 10% BSA: 
Dissolve 10g BSA in 75 ml double distilled water bring to 100 ml with double 
· distilled water. 
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Dissolve 30g of KHC03 in double distilled water and make up to 100 ml. Store 
at -20°C. 
10. Reagent Mixture: 
Add 10 ml I.OM phosphate buffer and 100 µl of 5mM nadh to 90 ml double 
distilled water. Prepare fresh daily. 
Procedure 
A standard curve was prepared by adding 0, 10, 20, 40, 60, 80 and 100 µl (Fig. 
4) of acetoacetate standard to· tubes containing 100 µl 10% BSA, 300 µl 3.0M HC104 
and double distilled water to a total volume of 1.65 ml. The tubes were vortexed 
vigorously for 30 sec and allowed to sit in an ice water bath for 5 min vortexed again . . 
and centrifuged for 10 �n at 1500 X g at 2°C. The supernatant was then poured off 
into another tube on ice. A 100 µl aliquot of the neutralized standard or tissue 
supernatant was added to 1.9 ml of reaction mixture in a 4.5 ml polystyrene Ultra-Vu 
disposable cuvette (Baxter Scientific Products, Atlanta, GA) and mixed by inversion. 
Baseline fluorescence was determined in a Hitachi F-2000 Fluorescence 
Spectrophotometer (Exitation 360 and Emission � nm) 10 µl of BHBDH was _ then 
added. . The cuvettes were mixed by inversion and let sit at room temperature for 60 
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Figure 4. Acetoacetate Standard Curve 
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min in the dark. After 60 min fluorescence was determined again. The decrease in 
fluorescence was proportional to the concentration of acetoacetate. 
Calculations 
Fluorescence X 1/slope X 5 = nmoles/ml plasma 
Fluorescence X 1/slope + mg liver = nmoles/mg liver 
Fluorescence X 1/slope X 10 = nmoles/ml urine 
3-Hydroxybutyric Acid Determination 
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3 Hydroxybutyric Acid was determined according to the procedure of Williamson 
and Mellanby (65) adapted for fluorescence. The concentration of NADH is measured 
by an increase in fluorescence as 3-Hydroxylbutyrate is oxidized to acetoacetate. 
Reagents 
1 .  2-Amino-2-methyl-1-propanol buffer (1 M; pH 10.0): 
Dissolve 8.9 g 2-amino-2-methyl-1-propanol (9.5 ml if liquid) in double distilled 
water, adjust pH to 10.0 with 12 M HCl and dilute to 100 ml. wit double 
distilled water. Store at -2D°C. 
2. Tris buffer (20 mM; pH 8.0): 
Dissolve 0.24 g Tris (Sigma, St. . Louis, MO) in double distilled water adjust pH 
to 8 with 1.0 m HCL add 200 pl 10% BSA and dilute with double distilled water 
to 100 ml. Store at -20°C. 
3 .  Hydrazine Hydrate (20 m) (Sigma, St. Louis, MO) 
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4. Nicotinamide-adenine dinucleotide (0. 1 M B-NAD Grade Ill) from yeast (Sigma, 
St. Louis, MO). 
Dissolve 70 mg. NAO in 1 ml double distilled water. Store at -20°C . 
5. Lactate dehydrogenase, LOH 
Dilute stock LOH, Bovine heart Type III in 2. 1 M (NH4)2S04 (Sigma, St. Louis, 
MO) with 20 mm Tris 
6. 1.0 mM 3-Hydroxybutyrate 
Dissolve 15.4 mg DL-3Hydroxybutyric Acid-Sodium salt (Sigma, St. Louis, MO) 
per ml double distilled water this yields a 0. 1 M solution. Dilute to i.o mM by 
adding 200 µl to 9.8 ml double distilled water. Make fresh daily. 
7. Perchloric acid (3 M): 
Dilute 25 ml. 70% HC104 with double distilled water to 100 ml. 
8. Potassium hydrogen carbonate (3 M): 
Dissolve 30 g. KHC03 with C:touble distilled water and make up to 100 ml. 
9. Reagent mixture 
Mix 10 ml buffer (1), 250 µl Hydrazine Hydrate and 50 µl NAO and bring to 
100 ml with double distilled water. Make fresh daily 
Procedure 
A standard curve was prepared by adding 0, 10, 20, 40, 60, 80 and 100 µl (Fig. 
5) of 3-Hydroxybutyrate standard to tubes containing 100 µl 10% BSA, 300 µl 3.0 M 
HC104 and double distilled water to a total volume of 1.65 ml. The tubes were 
vortexed vigorously for 30 sec and allowed to sit in an ice water bath for 5 min, 
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vortexed again and centrifuged for 10 min at 1500 x g at 2°C . . 1:0 ml of the 
supernatant was removed and added to another conical tube on ice. 200 µl of 3 M 
KHC03 were added and allowed to sit for 15 min, then centrifuged for 10 min at 1500 
x g at 2°C. The supernatant was then poured off into another tube on ice. A 100 µl 
aliquot of the neutralized standard or tissue supernatant was added to 1 .9 ml of 
reaction mixture in a 4.5 ml polystyrene Ultra-Vu disposable cuvette (Baxter Scientific 
. . 
Products, Atlanta, GA) and mixed by inversion. Baseline fluorescence was �etermined 
in a Hitachi F-2000 Fluorescence Spectrophotometer (Exitation 360 and Emission 460 
nm). 10 µl . of BHBDH were then added, the cuvettes . were mixed by inversion a)Jd let 
sit at room temperature for 60 min in the dark. After 60 min fluorescence was 
determined again. The decrease in fluorescence was proportional to the concentration 
of 3-Hydroxybutyric Acid. 
Calculations 
Fluorescence X 1/slope X 5 = nmoles/ml plasma, urine 
Fluorescence_ X I/slope +. mg liver = nmoles/mg liver 
Fluorescence X I/slope x 10 = nmoles/mg liver 
Total Lipids Determination 
-Total lipids were determined according to the method of Ellenston and Caraway (66). 
Reagents 
1. Concentrated �S04 
2. Phosphoric Acid-V anillin Reagent 
Dissolve 1.0g vanillin in 160 ml double distilled water. Bring to 500 ml with 
concentrated phosphoric acid. Store at room temperature. 
3. Olive Oil standard (1 %) 
Mix l .Og of olive oil with 7.5 ml chloroform and bring to 100 ml with 
chloroform. Store at -2D°C. 
4. Working standard (0.1 % ) 
Mix 0.5 ml of 1 % standard with 4.5 ml chloroform. Store at -20°C. 
Procedure 
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A standard curve was prepared by adding 0, 50, 100, 200, and 400 µI (Fig. 6) of 
working standard to 16 X 150 mm glass tube. The chloroform was then evaporated 
off under a stream of nitrogen and 200 µI of double distilled water were added to each 
tube. 200 µI of plasma or 100 µI liver homogenate plus 100 µI doub_le distilled water 
were added to 16 X 150 mm glass tubes while the chloroform was evaporating off. 5 
ml of H2S04 were added to all tubes, vortexed and placed in a heating block at 100c 
for 10 min, then allowed to cool to room temperature. 200 µl from each tube were 
added to 3.0 ml of phosphoric acid-vanillin reagent, vortexed and placed in the dark 
for 1 hour. Absorbance was determined in a Beckman Model 34 Dual-Wavelength 
Spectrophotometer at 520 nm. 
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Figure 6. Total Lipids Standard Curve 
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Calculation 
Abs X 1/slope X 5 = mg lipid/ml plasma 
�bs X 1/slope X 10/mg liver/ml homogenate = mg lipid/mg liver 
Triglyceride Determination 
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Triglycerides were determined according to the method Geigel et al (67). Lipids 
are partitioned between water/isopropanol and nonane phases with the triglyceride 
extracted into the nonane. Glycerol is liberated from the triglyceride by sodium 
hydroxide and oxidized to formaldehyde by periodate. The formaldehyde reacts with 
2, 4-pentanedione to form 3,5-diacetyl- 1,3-dihydrolutidine, the color compound 
measured. 
Reagents 
1. Extraction reagent: n-nonane/isopropanol (2.0/3 .5 v/v). Caution: flammable. 
Not necessary to redistill. 
2. Triolein standard: triolein (Sigma Chem. Col, St. Louis, MO) 100 mg/dl in 
extraction reagent (1. 13 nmol/liter). 
3 .  Dilute sulfuric acid, 40 nmol/liter: 1. 10 ml cone. H2So4 diluted in small amount 
of distilled water and diluted to 500 ml. 
4. Transesterifying reagent: N aOH in isopropanol, 100 mmol/liter. 1 g Na OH is 
dissolved in small amount of isopropanol and diluted to 250 ml. A fine 
precipitate may be present in the reagent, primarily as a result of carbonate 
formation. It will settle on standing, or it can be removed by filtration. A slight 
yellow color may develop with age but will not affect test results. 
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5. Oxidizing reagent: sodium periodate (Nal04),  18 mmol/liter, in 2.0 mol/liter 
acetic acid (CH3COOH). 0.962 g of Nal04 is dissolved in 2 M acetic acid and 
diluted to 250 ml. 2 M acetic acid is prepared by adding 5 1  ml of glacial aceti� 
acid to some distilled water and dilute to 500 ml. 
6. Color buffer: Ammonium acetate (CH2COOHN4) (6.0 mol/liter, pH 6.0 at 25°C). 
462g CH2COONH4 is dissolved in approximately 600 ml distilled water. The pH 
is adjusted to 6.0 with glacial acetic acid (H). The solution is diluted to one 
liter. 
7. Acetylacetone (c;i80z) (2,4-pentanedione), reagent grade. 
8. n-Nonane (Phillips "pure" grade.) 
The above reagents all are stable for at least a year at room temperature . Store 
them in tightly stoppered vessels. 
9. Working color reagent: Add 4 ml of acetylacetone to 100 ml of the color buffer. 
Shake vigorously and allow to stand for at least 15 min. before use. This 
solution is stable for 8 hours at room temperature. 
Procedure 
A standard curve was prepared by adding 0, 50, 100, 200, 400 µl (Fig. 7) to 16 
X 100 mm glass screw-top tubes. Total volume was brought to 5.0 ml with extracting 
reagent. 200 µl of double distilled water were than added to each standard. 200 µl of 
liver homogenate or plasma was then added to tubes containing 5 .0 ml extracting 
reagent. The tubes were vortexed and centrifuged at 1500 x g at 2°C. 500 µl of the 
upper phase was added to an equal volume of transesterifying reagent, vortexed and 
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Figure 7. Triglyceride Standard Curve 
held at room temperature for five min. 500 µ1 of oxidizing reagent was added, 
vortexed and held at room temperature for five min. 6.0 ml of working color reagent 
was added and incubated at 60°C for ten min. The tubes were cooled to room 
temperature and absorbances was determined at 415 nm. 
Calculation 
Abs X 1/slope X 5 = mg Triglyceride/ml plasma 
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Abs X 1/slope X 5 = mg liver/ ml homogenate = mg Triglyceride/ml plasma 
Camitine Determination 
Carnitine was · determined by the method of Cederblad & Lindstedt (68) with 
modirications (69-7 1). Total carnitine is fractionated by PCA into non-esterified 
carnitine (NEC), acid soluble acylcarnitine (ASAC) and acid insoluble acylcarnitine 
(AIAC). The acylcarnitine fractions are first hydrolyzed with KOH then assayed as 
NEC. Labelled ([1-14C]AcetylCoA or [CH3-H]Acetyl CoA) acetyl CoA is then 
esterifiecf to NEC by carnitine acetyl transferase (CAT). Excess acetyl-CoA is 
removed by anion exchange chromotography. Radioactivity in the eluent which would 
be proportional to carnitine concentration, is determined by liquid scintillation. 
Procedure 
A standard curve was prepared by adding 0, 10, 20, 40, 60, 80, 100 µ1 (Fig. 8-
10) to plastic conical tubes and total volume was brought to 100 µ1 with double 
distilled water. , 100 µ1 BSA and 200 µ1 PCA were added to each tube. Plasma was 
assayed by adding 100 µl plasma to 100 µl double distilled water and 200 ml PCA. 
Liver camitine was determined by mixing 200 µI liver homogenate with 200 µl PCA. 
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100 µl of urine sample were mixed with 100 µl BSA before the addition of PCA. (It 
is necessary to dilute urine (with normal saline) from carnitine supplemented rats 20-
30 fold in order to determine NEC and ASAC and 10 fold for AIAC). The tubes were 
vortexed," centrifuged at 1500 X g for 10 min at 4°C (Model TJ-6, Beckman 
Instruments, Palo Alto, CA) and put on ice. 
Reagents 
1. 0.5 mM carnitine standard solution (stock): 9.88 mg L-carnitine HCL (sigma 
Chemical Co., St Louis, MO) was dissolved in cold glass distilled water (GDW) 
and diluted to 100 ml in a volumetric flask. This stock standard was diluted 1 :2 
to give a working standard concentration of 0.25 mM. 
2. 22.90 mM L-palmitoylcarnitine standard (stock): 1 .0 ml of GDW was added to a 
vial containing 10 ml of L-palmityl camitine (Sigma Chemical Co., St. Louis, 
MO). This stock standard was diluted 1: 100 to give a working standard 
concentration of 0.229 mM. 
3 .  Carniti�e standard tµixture: Working standard were prepared by mixing equal 
volumes of L-carnitine and L-palmitoyl carnitine. 
4. 0.5 M Potassium hydroxide: 28.05 g of KOH was dissolved in some GDW and 
diluted to a volume of 1 liter. 
5. 0.5 M Potassium hydroxide: 56. 11 g of KOH was dissolved in some GDW and 
diluted to a volume of 250 ml. 
6. 0.6 M Perchloric acid (PCA): 51.26 ml of 70% PCA was added in some GDW 
and diluted to a volume of 1 liter. 
7. 0. 1 M Sodium tetrathionate: 0.6756 g of anhydrous sodium tetrathionate (J.T. 
Baker Chem. Co., Phillipsburg, NJ) was dissolved in GDW and diluted to a 
volume' of 25 ml. 
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8 .  0. 1 % Phenol red: 100 mg of phenol red (Sigma Chemical Co., st. Louis, MO) 
was dissolved in absolute ethanol and made to a volume of 100 ml. Phenol red 
tubes were prepared by adding one drop of phenol red to 12 x 75 mm Pyrex 
glass tubes and allowed to dry. 
9. [ 1-14C] acetyl Coenzyme A: 10 uCi of [3H] acetyl Coenzyme A (New England 
Nuclear, Boston, MA) was dissolved in cold GDW and made to a volume of ·300 
ml. 5.0 ml aliquots were dispensed into plastic vials and frozen at -7CY'C. 
10. IM Potassium bicarbonate: 1 g potassium bicarbonate (Certified ASC, Fisher 
Scientific Co., Fair Lawn, NJ) was dissolved and made to a volume of 10 ml 
with GDW. Solution was stored at room temperature and made daily. 
1 1. 0. 1 M acetic anhydride: 0.5 ml of acetic anhydride (Fisher Scientific Co., Fair 
Lawn, NJ) was added to 4.95 ml of cold GDW and used immediately for acetyl 
CoA solution. 
12. 0. 1 mM acetyl Coenzyme A: 10 mg of acetyl Coenzyme A (Sigma Chemical 
Co., St. Louis, MO) was added tO' 0.5 ml cold GDW and mixed. Then, 100 µl of 
1 M potassium bicarbonate was added and mixed, and followed by the addition 
of 200 µl of 0. 1 M acetic anhydride. The solution was made up to 80 ml with 
cold GDW, mixed thoroughly, and dispensed into plastic vials and frozen at -
10°c. 
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13.  Camitine acetyltransferase (CAT): CAT from pigeon breast muscle (Sigma 
Chemical Co., St Louis, MO) was diluted with GDW to give an enzyme activity 
of 50 units/ml. 
14. 1 M [3-(4-morpholino)propanesulfonic acid]MOPS: 20.92 g of MOPS (Sigma 
Chemical Co., St Louis, MO) was added to about 80 ml of GDW. The pH was 
adjusted 7.4 with 4 M potassium hydroxide and was diluted to a volume of 100 
ml with GDW. 
15. PCA/MOPS-1: 20.9 g of MOPS was added to 50 ml of 0.6 M PCA and brought 
up · to a volume of 100 ml with GDW. The solution was stored at 4°C. 
16. PCA/MOPS-11: 20.9 g of MPOS was added to 20 ml of 0.6 M PCA and brought­
up to a volume of 100 ml with GDW. The solution was stored at 4°C. 
17. 0. 1 M ethylene glycol-bis (beta-amino-ethylether) N, N-tetraacetic (EGTA), pH 
7: 1.902 g EGTA (Sigma Chemical co., St. Louis, MO) was added in 30 �l 
GDW, adjusted to pH 7.0 with 4 M potassium hydroxide, and diluted to 50 ml 
with GDW. 
18. 0. 1 mM [3H] acetyl Coenzyme A solution: 2: 1 volumes of [l-14C]acetyl CoA 
and 0. 1 mM acetyl CoA were mixed and stored at 4°C. 
19. Reagent mixture for one assay: 1 M MOPS, pH 7.4 ,  120 µl; 0. 1 M EGTA, pH 
7.0, .20 µl; 0. 1 M sodium tetrathionate, 20 µl; 0. 1 mM [l-14C]-acetyl CoA 
solution, 200 µl; GDW, 40 µl; to a volume of 400 µI. 
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20. 8% bovine serum albumin (BSA): 4 g of BSA (Fatty acid poor, Fraction V, ICN 
Pharmaceuticals Inc., Life Sci. Group, Cleveland, OH) was dusted into about 20 
ml of GDW, stirred gently, and diluted to 50 ml. 
21 .  Scintillation fluid; Ready-Solv@CP (Beckman . Instruments, Palo Alto, CA). 
22. Mini Columns: The mini columns were made by stuffing the area above 5-3/4" 
Pasteur pipettes (Fisher Scientific Co., Fair Lawn, NJ) with glass wool. Anion 
Exchange Resin, AG I-X8, 200-400 mesh, CL-form (Bio-Rad Laboratories, 
Richmond CA) was added up to the 9 cm mark measured from the tip of the 
pipette. 
Nonesterified Camitine Determination 
35 pl of 1 M potassium bicarbonate was added to the 150 pl of the supernatant 
in a phenol red test tube and vortexed. The contents turned a golden yellow color. 
The mixtures were held for 30 min on ice and centrifuged at 1500 x g for 10 min. 
Acid Soluble Acylcarnitine Determination 
75 pl of 0.5 M potassium hydro�ide was added to the 100 pl of the supernatant 
in the phenol red test tube and vortexed. The contents turned a purple-red color 
indicating alkalinity for hydrolysis. The contents were incubated in a 37°C rotating 
water bath ( 100 shakes/min) for 30 min for complete hydrolysis. The mixtures were 
then neutralized by adding 30 pl of PCA/MOPS-11, and vortexed. They were held on 
ice for 30 in and centrifuged at 1500 x g for 10 min. . . 
Acid Insoluble Acylcamitine Determination 
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The pellet was resuspended in 200 µl of 0.6 M PCA and centrifuged at 1500 x g 
for 10 min, drained by inverting the tube and repeated. One drop of phenol red 
indicator and 200 µl of 0.5 M potassium hydroxide were added to each tube and the 
pellets were resuspended. The contents turned a purple-red color and were hydrolyzed 
in a 65°C shaking water bath (100 spm) for 60 min. 
The contents were neutralized by adding 100 µl of PCA/MOPS-1. The tubes 
were vortexed, held on ice for 30 min and centrifuged at 1500 x g for 10 miri at 4°C. 
Assay for Carnitine 
A 100 µl aliquot was transferred from each of the fractions to 1.5 ml microfuge 
tubes separately. Four hundred µl of reagent mixture were added followed by 20 µl of 
carnitine acetyltransferase (CA n. The tubes were capped, mixed by gentled tapping, 
incubated in a 37°C shaking water bath for 30 min. Later, 200 µl of the incubated 
mixture was transferred onto a mini column, and the eluant was collected into plastic 
mini scintillation vial. When the 100 µl aliquot was fully absorbed, the column was 
washed with 2 portions of 500 µl GDW, and the washe� were also collected into the 
same respective scintillation vial. Then, 5 ml of scintillation fluid was added to each 
vial, capped, shaken, wiped-off with ethanol, counted for 10 min/vial in a scintillation 
counter (LS-3801 Beckman Instruments, Irving, CA). 
Calculation 
DPM x I/slope x 10 - nmoles/ml plasma 
DPM x I/slope x 5 + mg Liver/ml homogenate = mg liver 
Ethanol Determination 
Ethano� was determined by the procedure of Bernt and Gutmann (72). As 
ethanol is oxidized to acetate by alcohol dehydrogenase the reduction of NAO to 
NAOH is followed spectrophotometrically. 
Reagents · 
1. 0.5% (v/v) Ethanol: 
5 1  
Add 500 µl absolute ethanol to 100 ml volumetric flask containing 75 ml of cold 
double distilled water and bring up to mark with cold double distilled water. 
Dilute the 0.5% ethanol 50 fold to yield working standard 0.01 % ethanol. 
2. Sodium pyrophosphate buffer: 
(75 mM pyrophosphate buffer, pH 8.7, 75 mM semicarbazide, 21 mM glycine). 
Dissolve 33.3 g N�P207 X 10 �O + 8.25 g semicarbazide HCl + 1.65 g glycine 
in 800 ml distilled H20, adjust to pH 8.7 with about 16.7 ml 4N KOH and dilute 
to 1 liter with double distilled water. Stable for two weeks at 4°C. 
3. Nicotinamide-adenine dinucleotide: 
(24mM B-NAO Type m from yeast (Sigma, ST, Louis, MO). Dissolve 83.3 mg 
NAO in 5.0 ml double distilled water. Make fresh. 
4. Alcohol dehydrogenase: 
Dissolve 10.0 mg of lyophilized enzyme (Sigma, St. Louis, MO) in 1.0 ml GOW 
( 10 mg/ml). Make fresh. 
5. Reagent Mixture: 
For one assay, 2.38 ml buffer, 100 µl NAO and 20 µl AOH. 
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Procedure 
A standard curve was prepared by adding 0, 25, 50, 75 and 100 µ1 (Fig. 1 1) of 
working st�dard to 16 X 125 plastic tubes. Total volume was brought to 100 µ1 with 
double distilled water. Then, 2.5 ml of reagent mixture were added to each tube. A 
100 µ1 aliquot of 50 fold diluted blood or 1 :3 fold diluted neutralized PCA supernatant 
of liver sample was added to tubes containing 2.5 ml reagent mixture. The tubes were 
very gently vortexed and incubated at 37°C for 25 min in a shaking water bath. After 
cooling to room temperature absorbance was determined at 340 nm with a Beckman 
Model 34 Dual-Wavelength Spectrophotometer. 
Calculations 
Abs X I/slope x 50 = ug ethanol/ml blood 
Abs x I/slope x 3 + mg liver/ml PCA sn 
STATISTICS 
All ·data are presented as group means ± the standard error of the mean. The 
paired t-test was used to analyze the data from 14C02 analysis. The students t-test was 
used to analyze data between 2 groups (91) and Duncan's Multiple Range Test was 
employed if there were more than 2 groups (98 ). 
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Figure 1 1 . Ethanol Standard Curve 
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CHAPTER IV 
RESULTS 
Experiment 1 [l-14C]-Ethanol Oxidation 
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Dietary carnitine supplementation for 7d resulted in a decrease in the oxidation 
of [l-14C]-ethanol to 14C02 (Table 1). The amount of 14C02 present in the KOH traps 
is lower at all time points and significantly reduced at hours 4-12 in the CS group. 
The CS group also expired less 14C02 as a percentage of the .total dose. The decrease 
in the percentage of total expired 14C02 in the CS group gradually increases from 0.5% 
at 1 h to 10.2% by 12 h (Table 1). By 24 h the NS and CS groups had expired 85.4% 
and 75.2% of the total dose as CO2• In terms of both the total expired 14C02 and 
percentage of the total dose, dietary carnitine supplementation results in the inhibition 
of ethanol oxidation. This is consistent with earlier observations reporting elevated 
blood-ethanol concentrations with the CS diet (14, 15). 
The urinary excretion of the 14C-label, which theoretically could have been 
ethanol, acetaldehyde, acetate, or any metabolite that acetate could be incorporated 
into, is shown in Table 2. There is no significant difference in the 12 h urine volume 
between the NS (20.4ml) and CS (22.3 ml) groups. The total DPM in the urine after 
12 h was also not significantly different between the NS (4.86 X 105) and CS (5.05 X 
108) groups. The percentage of the total dose excreted in the urine after 12 h was · 
2.95� in the NS group and 2.9 1  % in the CS group. Thus, carnitine is not affecting 
blood-ethanol concentrations by inhibiting ethanol or its metabolites excretion by the 
kidneys. 
TABLE 1 
EFFECT OF L-CARNITINE SUPPLEMENTED DIET ON [ l - 14C]-E1HANOL OXIDATION.1 
Hr. Post-Ethanol 
Administration 
1 
2 
3 
4 
5 
6 
7 
8 
10 
12 
DPMs x 10-6 
0.54 
1.21 
1.90 
2.82 
3.60 
4.82 
6.12 
7.97 
11.31 
15.00 
NS 
% of Dose 
3.1 
6.9 
10.8 
16.1 
20.5 
27.4 
34.8 
45.4 
64.4 
85.4 
1. Oxidation of ethanol is represented as expired 14002• All values are group means ± SEM (n=3) 
Groups 
· DPMs x 10-6 
0.48 
1.02 
1.60 
2.34* 
3.12** 
4.35** 
5.46*:" 
7.27** 
10.40* 
13.73** 
NS = nonsupplemented. CS = L-camitine supplemented. 
* p S 0.05 
**p S 0.01 
cs % of Dose NS - % of Dose CS 
% of Dose % NS-CS 
2.6 0.5 
5.6 1.3 
8.8 2.0 
12.8 3.3 
17.1 3.4 
23.8 3.6 
29.9 4.9 
39.8 5.0 
57.0 7.4 
75.2 10.2 
VI 
VI 
TABLE 2 
URINARY EXCRETION OF 14C-LABEL FOR TWELVE HOURS 
AFTER ETHANOL D0SE1 
Parameter 
12 hr Urine 
Volume (ml) 
NS 
20.4 ± 3.0-
Groups 
cs 
22.3 ± 3.9· 
56 
Total DPM 
% Dose 
4.86 X H>5 ± 3.7 X 1<>4-
2.95 ± 0.36. 
5.05 X 1()5 ± 3.3 X 104• 
2.91 ± o.2s· 
1. All values � group means ± SEM (n=5). 
Those bearing the same superscript within a row are not significantly different 
(p > 0.05). 
NS = Nonsupplemented 
CS = L-carnitine supplemented 
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The distribution of the 14C-label remaining in the body 12 h after ethanol 
administration was measured by determining the DPM in several tissues (Table 3). 
There were rio significant differences in the DPM in plasma, liver, kidney, heart, brain, 
skeletal muscle, and the epididymal fat pad between the NS and CS groups, 
respectively. The highest concentration of radioactivity was in the plasma followed by 
the liver, kidney, heart, brain, skeletal muscle, and the epididymal fat pad for both the 
NS and CS groups. Assuming skeletal muscle, fat and blood represent 50%, 20%, and 
6%, respectively, of total body mass, and using the actual weights of other organs. It 
was possible to account for approximately 95% of the total dose being expired as CO2, 
excreted in the urine or remaining in the body. 
In summary, carnitine supplementation reduced the amount of ethanol oxidized to 
CO2 over a 12  h period with 85% {NS) and 75% (CS) of the to� dose being expired 
as CO2• There was no effect of carnitine supplementation on urine volume, the 
excretion of the label, or tissue distribution of the label 12  h after ethanol 
administration. 
Experiment 2 Blood and Liver-Ethanol Concentrations and Redox State 
Cami tine supplementation for 7 d resulted in 30% higher blood-ethanol 
concentrations, which were 88.52 and 125.99 mg/di in the NS and CS groups, 
respectively (Table 4). Since plasma-ethanol concentrations are 1 . 12 times higher than 
whole blood-ethanol concentrations (94), it would be expected that plasma DPM 
concentrations would also be higher in the carnitine supplemented group. Three hour 
plasma-DPM concentrations were 3 1 ,800 and 33,800 DPM/ml for the NS and CS 
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TABLE 3 
EFFECT OF SUPPLEMENTARY CARNITINE ON 14C TISSUE DISTRIBUTION 
TWELVE HOURS AFIER [l-14C]-ETHANOL ADMINISTRATION. 
Groups 
Tissue NS cs 
Plasma 80.78 ± 5.38· 75. 17 ± 2.99· 
Liver 22. 10 ± 3. 1� 28 .54 ± 5.44. 
Kidney · 20.20 ± 1 .  90- 21 .40 ± 1 .48· 
Heart 9. 10 ± 0.18· 9.24 ± 0.97. 
Brain 4.56 ± 0.82· 4. 18 ± 0.2 1· 
Skeletal Muscle .4.28 ± 0.82· 4.24 ± 0.65. 
Epididymal 1 .93 ± 0.2� 3.72 ± 2.35· 
Fat Pad 
1 .  14C distribution is expressed as DPM/mg tissue or ml plasma. All values are ·group 
means (n=5), those bearing the same superscript within a row are not significantly 
different (p > 0.05). 
NS = Nonsupplemented 
CS = Camitine supplemented 
TABLE 4 
BLOOD AND LNER ETHANOL CONCEN1RA TIONS AND 14C CONTENT 
THREE HOURS AFfER E1HANOL ADMIN1STRATI0N1 
GROUPS 
Tissue NS cs % NS/CS 
Blood Ethanol 88.52 ± 5.78· 125.99 ± 1.57b 70% 
(mg/ell) 
Plasma DPM 31,800 ± 360()& 33,800 ± 3000- 94% 
(DPM/ml) 
Liver Ethanol 1.70 ± 0.21· 0.85 ± 0.08b 200% 
(µg/mg) 
Liver DPM 
(DPM/mg) 34.90 ± 1.& 36.31 ± 1.90- 96% 
1. All values are group means ± SEM (n=5). Those bearing the same superscript 
within a row are not significantly different (p > 0.05). 
NS = nonsupplemented, CS = L-carnitine supplemented 
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groups, respectively (Table 4). Carnitine supplementation resulted in elevated blood-
ethanol concentrations without the expected rise in plasma-DPM concentrations. 
The effect of carnitine supplementation on liver-ethanol concentrations is opposite of 
the blood-ethanol concentrations. Liver-ethanol concentrations were 1 .  70 and 0.85 
µg/mg in the NS and CS groups, respectively. However, as in the plasma, there were 
no significant differences with respect to liver-DPM concentrations between the NS 
(34.9 DPM/mg) and CS (36.3 DPM/mg) groups. 
The oxidation of ethanol leads to an excess of NADH and a shift in the redox 
potential of the liver to a more reduced state ( 10, 1 1 , 94). It is possible to access the 
cytosolic redox state by measuring the lactate/pyruvate ratio and the inner-
' mitochondrial redox state by measuring 3-hydroxybutyrate/acetoacetate ratio. 
Carnitine supplementation did not significantly affect liver pyruvate and _ lactate 
concentrations and there were no significant differences in the lactate/pyruvate ratio 
between the NS (22. 17) and CS ( 19.98) groups (Table 5). Ethanol administration 
lowered liver pyruvate concentrations, raised liver lactate concentration and doubled 
the lactate/pyruvate ratio �hen compared to non-ethanol treated rats (Table 5). 
Acetoacetate and 3-Hydroxybutyrate concentrations in the liver were not significantly 
different between the NS and CS groups (Table 5). There were also no significant 
differences in the 3-hydroxybutyrate/acetoacetate ratio between the NS (54.57) and the 
CS (5 1 .29) groups (Table 5). Ethanol administration lowered liver acetoacetate 
concentrations, raised liver 3-hydroxybutyrate concentrations and increased the 3-
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TABLE 5 
LIVER REDOX PAIR CONCENTRATIONS THREE HOURS AFrER ETHANOL 
ADMINISTRA TION2 
Groups 
Metabolite NS cs %NS/CS 
(nmoles/g liver) 
Pyruvate 68.65 ± 9.96· 88.72 ± 17. 13· 77% 
(130)2 
Lactate 2441 .1 ± 426.9. 2490.5 ± 251_5• 98% 
(1620)2 
LIP 22. 17 ± 4.oo· 19.98 ± 0.70- 1 1 1% 
Acetoacetate 14.00 ± 2.41• 13.20 ± 2.80- 06% 
(55)2 
3-Hydroxybutyrate 728.25 ± 15.59. 622.0 ± 65. 17. 1 17% 
(144)2 
H/A 54.57 ± 3.87� 5 1 .29 ± 4.3 1· 106% 
1 .  All values are group means ± SEM (n=5). Those bearing the same superscript 
within a row are not significantly different (p > 0.05). · 
NS = Nonsupplemented 
CS = L-camitine supplemented 
LIP = Lactate/Pyruvate 
H/A = 3-Hydroxybutyrate/Acetoacetate 
2. Values in parenthesis are from fed control rats (93). 
Hydroxybutyrate/acetotate ratio from about 3 to 50 when compared to non-ethanol 
treated rats (Table 5). Plasma pyruvate concentrations were lowered by ethanol 
administration but were not significantly different between the NS (8 1.6 nmoles/ml) 
and CS (75.6 nm<?les/ml) groups (Table 6). Ethanol administration elevated plasma 
lactate concentrations when compared to non-ethanol treated rats which is consistent 
with earlier reports of lactic acidosis following ethanol administration (39.96). 
Carnitine supplementation significantly increased plasma lactate concentrations from 
3553 (NS) to 6849 (CS) nmole/ml (Table 6). The lactate/pyruvate ratio was also 
increased from 44 (NS) to 74 (CS) by carnitine · supplementation (Table 6). Plasma 
acetoacetate concentrations were not significantly affected by either ethanol 
administration or camitine supplementation (Table 6). Plasma 3-hydroxybutyrate 
concentrations and 3-hydroxybutyrate/acetoacetate were elevated by ethanol 
administration but not significantly affected by c·arnitine supplementation (Table 6) 
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Carnitine supplementation had a dramatic effect on plasma and liver camitine 
concentrations 3h after ethanol administration (Table 7). Plasma concentrations of 
NEC were significantly increased from 33 (NS) to 54 (CS) nmoles/ml. Plasma 
concentrations of ASAC were significantly increased from 6.94 (NS) to 16.48 (CS) 
nmoles/ml of AIAC were significantly increased from 13.94 (NS) to 23.96 (CS) 
nmoles/ml. Liver NEC concentrations were 1.3 times in the CS group (199 vs 265 
nmoles/g). Liver ASAC was 2.3 times higher (27 vs 63 nmoles/g) and AIAC was 2.7 
times higher (8.7 vs 23.6 nmoles/g) in the CS group (Table 7). 
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TABLE 6 
PLASMA REDOX PAIR CONCENTRATIONS THREE HOURS AFI'ER ETHANOL 
ADMINISTRA TION2 
Groups 
Metabolit� NS cs % NS/CS 
(nmoles/ml) 
Pyruvate 81.6 ± 6.0- 75.6 ± 4.8· 108% 
(234)2 
Lactate 3553.0 ± 331.0- 6849.0 ± 1388.0b 52% 
(2960)2 
LIP 43.53 ± 2.43. 73 .92 ± 8.79b 59% 
Acetoacetate 116.0 ± 21.2· 68.4 ± 16.4& 170% 
(76)2 
3-Hydroxybutynlte 395.2 ± 106.0- 260.8 ± 50. 86& 152% 
(82)2 
H/A 3.51 ± 0.68& 3.19 ± 0.98& 110% 
1. All values are group means ± SEM (n=5). Those bearing the same superscript within 
a row are not significantly different (p > 0.05). 
NS = Nonsupplemented 
CS = L-camitine supplemented 
LIP = Lactate/Pyruvate 
HI A = 3-Hydroxybutyrate/ Acetoacetate 
2. Values in parenthesis are from fed control rats (93 ). 
TABLE 7 
PLASMA AND LIVER CARNITINE CONCENTRATION THREE HOURS AFIER 
ETIIANOL ADMINISTRA TION1 •2 
Groups 
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�amitine 
Fraction 
NS cs % NS/CS 
Plasma (nmoles/ml) 
NEC 
ASAC 
AIAC 
Total 
Liver (nmoles/g) 
NEC 
ASAC 
AIAC 
Total 
33.32 ± 1 .88· 
6.97 ± 1 .73· 
1 3.94 ± 1 .91 •  
54.23 ± 5.52· 
199.64 ± 1 1 .74• 
27 .44 ± 4.6Cr 
8.67 ± 3.37• 
235.75 ± 19.1 r 
54.08 ± 2.3 1b 
16.48 ± 1 .73b 
23.96 ± 7.43b 
94.52 ± 7.43b 
264.64 ± 20.08b 
63.41 ± 5.02b 
23.6 1 ± 2.62b 
35 1 .66 ± 27.75b 
62% 
42% 
58% 
57% 
75% 
43% 
37% 
67% 
1 .  All values are group means ± SEM (N=5). Those bearing the same superscript 
within a row are not significantly different (p > 0.05). 
NS = nonsupplemented, CS = L-camitine supplemented 
2. All NEC and ASAC values should be multiplied by a factor of 2. 
Experiment 3 Urinary Excretion of [l-14C]-Ethanol 
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Urine volume over 24h period following ethanol a�nistration was not significantly 
different between the NS and CS groups (Table 8, Figure 12). Total 24h urine volume 
for the NS and CS groups was 26.8 and 27.9 ml, respectively. The largest volume was 
excreted in the first 3h and accounted for about 50% of the total 24h volume. The 3h 
urine volume is approximately equal to the volume of the gavage. From 3-6 h urine 
volume drops sharply followed by a linear increase over the next 18h (Figure 12). Food 
intake over the 24h period was not significantly different between the NS (18.4g) and CS 
(18.4g) groups (Table 8).Water intake over the 24h period was not significantly different 
betw�en the NS (31.2 ml) and CS (32.4 ml) groups (Table 8) 
The excretion of ethanol in the urine for 24h was not significantly affected by 
carnitine supplementation (Table 9, Figure 12). Total 24h ethanol for the NS and CS 
groups was 29.35 and 26.36 mg, respectively. This accounted for 2.9% of the total 
ethanol dose in the NS group and 2.6% in the CS group. The greatest amount of ethanol 
excreted in the urine was in the first 3h following ethanol administration. By 3h the NS 
group excreted 77% of the total 24h ethanol and the CS group 84% of the total 24h 
ethanol. After the initial 3h period ethanol excretion drops sharply and remains low for 
the remainder of the 24h period. 
The total amount of radioactivity excreted over the 24h period was not significantly 
affected by carnitine supplementation (Table 9, Figure 12). Total 24h excretion · of the 
14C-label was not significantly different between the NS (1.28 X 1()6 
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TABLE 8 
TWENTY FOUR HOUR FOOD AND WATER INTAKE AND URINARY OUTPUT 
FOLLOWING ETHANOL GAV AGE IN RA TS FED NS AND CS DIETS FOR SEVEN , DAYS2 
Parameter 
24 hr Food (g) 
intake 
24 hr Water (ml) 
intake 
NS 
18.4 ± ur 
31.2 ± 3.0-
Orpups 
cs 
18.4 ± 0.9' 
32.4 ± 4.1· 
Urine Volume - (ml) 
0-3 hr 
3-6 hr 
6-12 hr 
12-24 hr 
Total 
11.52 ± 1.13• 
1.66 ± 0.21· 
4.46 ± 0.70-
9.16 ± 1.01• 
26.80 ± 3.11' 
14.04 ± 1.24• 
2.24 ± 0.90' 
3.38 ± 0.74' 
8.28 ± 0.39' 
27 .94 ± 3.21· 
1. All values are group means ± SEM (n=5). Those bearing the sa�e superscript within 
a row are not significantly different 
(p > 0.05. 
NS = Nonsupplemented, CS = L-carnitine supplemented 
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TABLE 9 
1WENTY FOUR HOUR URINARY ETHANOL EXCRETION IN RATS FED NS 
AND CS DIETS FOR SEVEN DA YS2 
Groups 
Parameter 
Urine Ethanol (mg) 
0-3 hr 
3-6 hr 
6- 12 hr 
12-24 hr 
Total 
% Total Dose 
Urine DPM (total) 
0-3 hr 
3-6 hr 
6- 12 hr 
2-24 hr 
Total 
% Total Dose 
NS 
22.60 ± 66.50-
2.02 ± 0.90-
1 .66 ± 0.46· 
1 .00 ± 0. 10• 
29.35 ± 9.3 1. 
2.90 ± 0.45• 
5.63 X 1()5 ± 1 .01 X 105• 
1 .57 X 1()5 ± 5 . 1  X l<r 
4. 1 1  X lOS ± 6.5 X lcta 
1 .52 X 105 ± 1 .6 X 1()4• 
1 .28 X 106 ± 2.36 X 104& 
6.35 ± o.s2· 
cs 
22. 17 ± 7.42• 
1 .24 ± 0.52• 
2.02 ± 0.36· 
o.90 ± 0.40• 
26.36 ± 8.12· 
2.60 ± 0.538 
5.68 X lW ± 6.8 1 X 104• 
9.42 X 1()4 ± 2. 16 X 103• 
3.36 X lOS ± 5.3 1 X 103• 
1 .77 X lOS ± 2.29 X 103• 
1 . 1 5  X 106 ± 1 .69 X 105• 
5.72 ± 0.73· 
1 .  All values are group means ± SEM (n=3 for NS and CS groups, n=5 for NSE and 
CSE groups). Those bearing the same superscript within a row are not significantly 
different 
(p > 0.05. 
NS = Nonsupplemented, CS = L-camitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-camitine supplemented + ethanol 
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DPM) and CS (1. 16 X 1()6 DPM) groups. Over 24h the NS group had excreted 6.35% of 
the total dose and the CS group had excreted 5.72% of the total dose. The greatest 
amount of 14C-label was excreted in the first 3h and accounted for 44% (NS) and 
49%(CS) of the total 24h excretion. Over the next 3h there was a sharp drop in urinary 
radioactivity, followed by an increase from 6-12h (Figure 12). In the final 12h only a 
small amount of the 14C-label was excreted. 
. . Dietary carnitine supplementation resulted in dramatic increases in the concentration 
of carnitine in the urine (Table 10). CS rats had a 156 fold increase in NEC 
concentrations, a 62 fold increase in ASAC concentrations and an 1 1  fold .increase in 
AIAC concentrations for the first 3h (Table 10). Over the next 3h period CS rats had a · 
144 fold increase in NEC concentrations, a 23 fold increase in ASAC concentrations and 
a 86 fold increase in AIAC concentrations (Table 10). From 6-12h the CS rats had a 52 
fold increase in NEC concentrations, a 3 fold increase in ASAC concentrations and a 16  
fold increase in AIAC concentrations (Table 10). In the final 12h period the CS rats had 
a 42 fold increase in NEC concentrations, a 83 fold increase in ASAC concentrations and 
a 43 fold increase in AIAC concentrations (Table 10). 
Urinary excretion of the total amount of carnitine (nmoles/ml X uri�e volume) was 
also significantly increased in the CS group (Table 1 1 ). In the first 3h the CS rats had 
162 fold increase in NEC, a 58 fold increase in ASAC and a 27 fold increase in AIAC, 
(Table 1 1 ). _From 3-6h the CS rats had a 97 fold increase in NEC, a 13  fold increase in 
ASAC and a 46 .fold increase in AIAC (Table 1 1 ). From 6- 12h the CS rats had a 39 fold 
increase in NEC, a 5 fold increase in ASAC, a 22 fold increase in AIAC (Table 1 1). In 
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TABLE 10 
TWENTY FOUR HOUR URINARY CARNITINE CONCENTRATIONS 
FOLLOWING ElHANOL GAVAGE IN RATS FED NS AND CS DIETS FOR SEVEN 
DAYS1•2 
Carnitine Groups 
Fraction NS cs 
(nmolesJml) 
0-3 hr 
NEC 4.33 ± 1.08· 674.5 ± 93.lb 
ASAC 5.78 ± o.58. 359.3 ± 38.2b 
AIAC 0.58 ± 0. 12· 6.47 ± 0.46b 
3-6 hr 
NEC 7.76 ± 1.48. 1 122.2 ± 127.2b 
ASAC 8.85 ± 2.52• 207.5 ± 66.lOb 
AIAC 0. 19 ± 0.04• 16.3 1 ± 3 . 16b 
6-12 hr 
NEC 34 .26 ± 9.01 • 1788.3 ± 263 .7b 
ASAC 25.87 ± 12. 13• 86.79 ± 23 .2 1  b 
AIAC 1.36 ± 0.67· 22. 14 ± 5.43 b 
12-24 hr 
NEC 49.89 ± 12.98· 2069.3 ± 203 .4b 
ASAC 12.65 ± 3.66· 1048.9 ± 57.09b 
AIAC 0.38 ± 0. 12· 16.26 ± 1.0lb 
1. All values are group means ± SEM (n=3 for NS and CS groups, n=5 for NSE and 
CSE groups). Those bearing the same superscript within a row are not significantly 
different 
(p > 0.05. 
NS = Nonsupplemented, CS = L-carnitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-carnitine supplemented + ethanol 
2. All NEC and ASAC values should be multiplied by a factor of 2 
71  
TABLE 11 
TWENTY FOUR HOUR URINARY TOTAL CARNITINE EXCRETION 
FOLLOWING E1HANOL GAVAGE IN RATS FED NS AND CS DIETS FOR SEVEN 
DAYS1•2 
Carnitine Groups 
Fraction NS cs 
nmoles/time period 
0-3 hr 
NEC 50.77 ± 8. 14. 8,253 ± 878b 
ASAC 78.88 ± 13.40• 4,624 ± 329b 
AIAC · 3.02 ± 0�73• 8 1.7 ± 7.2b 
Total 293.53 ± 93. 19· 12,959 ± 1214b 
3-6 hr 
NEC 17.72 ± 3.20· 1,739 ± 254b 
ASAC 22.31 ± 10.59· 289 ± 66b 
AIAC 0.56 ± 0.26· 26. 1 ± 6. 14b 
Total 40.59 ± 14.05• 2,054 ± 326b 
6- 12 hr 
NEC 145.3 ± 45.6· 5,604 ± 962b 
ASAC 74.6 ± 20.1· 381.8 ± 90b 
AIAC 3.07 ± 0.18· 67.3 ± 13.8b 
Total 222.9 ± 61. 1 • 6,053 ± 1066b 
12-24 hr 
NEC 429.4 ± 86.60· 17, 137 '  ± 1352b 
ASAC 110.8 ± 28.90· 8,833 ± 8200b 
AIAC 3.02 ± 0.73· 124.3 ± 4b 
Total 543.20 ± 116.20· 26,094 ± 9556b 
1. All values are group means ± SEM (n=3 for NS and CS groups, n=5 for NSE and 
CSE groups). Those bearing the same superscript within a row are not significantly 
different 
(p > 0.05. 
NS = Nonsupplemented, CS = L-carnitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-carnitine supplemented + ethanol 
2. All NEC and ASA C values should be multiplied by a factor of 2 
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the final 12h the CS rats had a 40 fold increase in NEC, a 80 fold increase in ASAC, and 
a 41 fold increase in AIAC (Table 11.) 
Experiment 4 [14C(U)J Palmitate Oxidation Time Course 
Supplementation of the diet with carnitine did not increase the oxidation of [14C(U) ]­
palmitate to CO2 (Table 12). There was about a 4h lag between any detectable 14C02 and 
the palmitate gavage� From 4-24h the increase in 14C02 in the KOH traps was close to 
linear. There was no .effect of the length of time on the diets on palmitate oxidation with 
the total 24h 14C02 being essentially the same for 5, 10, 20, 30 and 40d. Both groups 
expired about 25% of the total dose as 14C02 by 24h. 
Since there were no significant differences in palmitate oxidation over the forty day 
period, ten and forty days were chosen to represent short and long term camitine 
supplementation. Plasma NEC concentrations were increased from 20.33 (NS) to 39.76 
. (CS) nmoles/ml in rats fed the diet for ten days (Table 13). Plasma ASAC 
concentrations were not significantly affected by ten days of supplementation. Plasma 
AIAC concentrations increased from �.81 (NS) to 6.30 (CS) but were not significantly at 
the 95% level of confide�ce. Forty days of supplementation also resulted in a significant 
increase of the NEC fraction 30.67 (NS) vs. 47.06 (CS) nmoles/ml. Forty day ASAC 
concentrations ·were almost doubled by camitine supplementation 6.8 1 (NS) vs 1 1 .51 
(CS), but owing to a large standard deviation were not significantly different at the 95% 
level of confidence (Table 13). Forty day AIAC concentrations were significantly 
elevated, 2.39 (NS) and 4.46 (CS) by c�itine supplementation 
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TABLE 12 
EFFECT OF L-CARNITINE SUPPLEMENTED DIET ON [14C(U)]-PALMITATE 
OXIDATION1 
Diet2 Time3 5 
NS 4 129 ± 58 
cs 4 155 ± 68 
NS .8  422 ± 144 
cs 8 385 ± 1 13 
NS 12 1540 ± 314 
cs 12 1 155 ± 204 
NS 24 1667 ± 354 
cs 24 1529 ± 80 
Days on Diet 
10 20 
59 ± 5 31 ± 17 
74 ± 38 30 ± 18  
262 ± 84 249 ± 47 
240 ± 13 342 ± 76 
827 ± 65 879 ± 100 
790 ± 1 14 8 1 8  ± 225 
1412 ± 196 1219 ± 1 8 1  
1428 ± 134 1228 ± 84 
30 40 
88 ± 20 68 ± 29 
1 18 ± 33 70 ± 13 
42 1 ± 125 29 1 ± 62 
440 ± 123 258 ± 38 
992 ± 434 972 ± 183 
1039 ± 156 753 ± 100 
1862 ± 289 1577 ± 369 
1775 ± 167 1544 ± 12 1 
1 .  Oxidation of palmitate i s  represented as expired 14C02 (DPM/rnl). All values are group means ± SEM (N=3). 
2. NS = Nonsupplemented. CS = L-carnitine supplemented. 
3. Hours after palmitate gavage. 
TABLE 13 
PLASMA CARNITINE CONCENTRATIONS IN RA TS FED NS AND CS DIETS 
FOR TEN AND FORTY DA YS 1 .2 
Groups 
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Carnitine 
Fraction 
(nmoles/ml) NS cs %NS/CS 
10d 
NEC 20.33 ± 1.65. 39.67 ± 0.55b 5 1% 
ASAC 8.07 ± 1 .69. 7.38 ± 1 .41• 9 1% 
AIAC 2.8 1 ± 4. 19. 6.30 ± 1 .3ga 45% 
Total 3 1.8 1  ± 4. 19· 53.44 ± 3.35b 59% 
40d 
NEC 30.67 ± 1 .97· 47 .06 ± 5 .53b 65% 
ASAC 6.8 1 ± 1 . 1 8· 1 1 .5 1 ± 3.2ga 59% 
AIAC 2.39 ± 0.09· 4.46 ± 0.61b 53% 
Total 39.87 ± 3.24. 63.03 ± 9 .43b 63% 
1 .  All values are group means ± SEM (N=3 for NS and CS groups). Those bearing 
the same superscript within a row are not significantly different (p > 0.05). 
NS = nonsupplemented, CS = L-carnitine supplemented 
2. All NEC and ASAC values should be multiplied by a factor of 2 
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(Table 13). In general, dietary supplementation for forty days was superior to ten days 
in elevating carnitine concentrations in the plasma. 
Liver ca.rnitine concentrations are presented in Table 14. There were no 
significant differences in NEC, ASAC, and AIAC concentrations between the NS and 
CS groups after 10d of carnitine supplementation. Thus the increased plasma 
concentrations of NEC and AIAC observed after 10d of camitine supplementation 
(Table 13) are not reflected in the liver (Table 14). However, by 40d liver NEC is 
25% higher, ASAC is 43% higher an� AIAC is 55% higher in the CS group (Table 
14). These differences would possibly be significant if the number of rats per group 
were. increased. CS groups (Table 15) at either ten or forty days. There were also no 
significant differences between 10d and 40d of supplementation with respect to total 
lipids in the plasma and liver. Plasma and liver triglycerides were not significantly 
different between the NS and CS groups (Table 16) at either 10d or 40d. There was a 
significant decrease in plasma triglycerides in both the NS and CS groups at 40d. 
However, since these values are not from the same rats at both 1 Od and again at 40d it 
is difficult to draw any conclusion due to the individual variability of triglycerides in 
the plasma. 
Experiment 5 (14C(U)J-Palmitate Oxidation with Ethanol 
The administration of ethanol 2h after [14C{U)]-palmitate gavage significantly 
reduced the amount of palmitate oxidized to CO2 for the next 22 hours (Table 17, 
Figure 13). However, supplementation of the diet with carnitine did not significantly 
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TABLE 14 
LIVER CARNITINE CONCENTRATIONS IN RATS FED NS AND CS DIETS FOR 
TEN AND FORTY DA YS 1 •2 
Camitine 
Fraction 
(nmoles/g) 
10d 
NEC 
ASAC 
AIAC 
Total 
40d · 
NEC 
ASAC 
AIAC 
Total 
NS 
154.3 1  ± 24.83· 
7 4.60 ± 36. 7'? 
2.91 ± 0.30• 
23 1 .83 ± 61 .93· 
206.46 ± 3.6<r 
144.58 ± 6.7 1 a 
4.96 ± 1 . 13• 
356.00 ± 1 1 .44• 
Groups 
cs 
163.40 ± 10. 18· 
77.68 ± 12.948 
3. 12 ± 1 .20· 
244. 12 ± 24.328 
273.43 ± 36.04. 
213.78 ± 50.03• 
8 .87 ± 1 .25• 
490.08 ± 87.328 
%NS/CS 
94% 
96% 
93% 
94% 
75% 
57% 
55% 
73% 
· 1 .  All values are group means ± SEM (n=3 for NS and CS groups). Those bearing 
the same superscript within a row are not significantly different ( p > 0.05). 
NS = Nonsupplemented, CS = L-carnitine supplemented 
2. All NEC and ASAC values should be multiplied by a factor of 2 
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TABLE 15  
PLASMA AND LIVER TOTAL LIPIDS IN RATS FED NS AND CS DIETS FOR 
TEN AND FORTY DA YS 1 
Groups 
NS cs % NS/CS 
Plasma (mg/dl) 
10d 285.96 ± 30.98· 264. 10 ± 16.48. 108% 
40d 3 16.06 ± 30. 10- 329.73 ± 23.94· 96% 
Liver (mg/g) 
10d 32. 16 ± 1 .74• 29.46 ± 0.44· 109% 
40d 30. 15 ± 1 .82· 33.02 ± 0.40- 91% 
1 .  All values are group means ± SEM (n=3 for NS and CS groups). Those bearing 
the same superscript within a row are not significantly different (p> 0.05). 
NS = Nonsupplemented, CS = 0.5% L-carnitine supplemented 
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TABLE 16  
PLASMA AND LIVER TRIGLYCERIDES IN RATS FED NS AND CS DIETS FOR 
TEN AND FORTY DA YS 1 
Groups 
NS cs % NS/CS 
Plasma (mg/dl) 
10d 77.90 ± 1 .12· 80.01 ± 0.841 97% 
40d 56.83 ± 1 .05• 53.41 ± 2.08· 106% 
Liver (mg/ g) 
10d 1 .78 ± 0.09· 1 .96 ± 0. 12• 9 1% 
40d 1 .37 ± 0. 19· 1 .68 ± 0. 13• 82% 
1 .  All values are group means ± SEM (n=3 for NS and CS groups). Those bearing 
the same superscript within a row are not sig�ificantly different (p> 0.05). 
NS = Nonsupplemented, CS = 0.5% L-carnitine supplemented 
TABLE 17 
. [
14C(U)]-PALMITATE OXIDATION WITH AND WITHOUT ETHANOL 
ADMINISTRATION IN RATS FED NS AND CS DIETS FOR TEN DAYS. 1 
Hours After 
Palmitate 0roQ1!S 
Gavage NS cs NSE CSE 
4 59 ± 5• 74 ± 38. 22 ± 17b 19 ± 12b 
6 ND ND 87 ± 19b 90 ± 17b 
8 262 ± 84· 240 ± 13• 164 ± 22b 103 ± 33b 
10 ND ND . 241 ± 25b 240 ± sob 
12 827 ± 65· 790 ± 1 14• 313 ± 36b 306 ± 66b 
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24 1412 ± 196. 1428 ± 134• 923 ± 112b 944 ± 171b 
1 .  All values are group means ± SEM (n=3 for NS and CS groups, n=5 for  NSE and 
CSE groups). Those bearing the same superscript within a row are not 
significantly different (p > 0.05). 
NS = Nonsupplemented, CS = L-camitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-camitine supplemented + ethanol 
ND = Not determined 
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Figure 13. Palmitate Oxidation With and Without Ethanol Administration 
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affect palmitate oxidation with or without ethanol administration (Table 17). The 
ethanol treated rats oxidized 69%, 35%, 62% and 35% less palmitate to CO2 at 4h, 8h, 
12h, and 24n, respectively . . 
Plasma NEC concentrations were significantly higher in carnitine supplemented 
rats 20.33 (NS), 39.76 (CS), 24.82 (NSE) and 43.06 nmoles/ml (CSE) (Table 18), but 
there was no significant effect of ethanol on NEC values. Plasma ASAC 
concentration was significantly reduced in the NSE group, but there were no 
significant differences between the NS, CS, and CSE groups. AIAC concentrations 
were not significantly different between the NS, CS, NSE, and CSE groups (Table 18). 
There were no significant differences in NEC and ASAC concentrations in the liver 
between NS, CS, NSE, and CSE groups (Table 19). Ethanol administration resulted in 
significantly elevated 2.92 (NS) and 3.12 (CS) vs 7.29 (NSE) and 12.16 (CSE) AIAC 
concentrations in the liver (Table 19). There was a 2.4 fold increase in the NSE group 
over the NS group and a 3.9 fold inc�ease in the CSE group over the �S group. 
However, comparing NS _ to CS and NSE to CSE groups revealed no significant 
differences in liver AIAC values. 
Plasma and liver total lipids were not significantly different between the NS, CS , 
. NSE and CSE groups (Table 20). Plasma triglycerides were also not significantly 
different between the four groups (Table 21). Ethanol administration resulted in a 3 
fold increase in liver triglyceride concentrations 1.?8 (NS) & 1.96 (CS) vs 5.20 (NSE) 
and 5.37 (CSE); but carnitine supplementation was without significant effect (Table 
21). 
82 
TABLE 18  
PLASMA CARNITINE CONCENTRATIONS WITH AND WIIBOUT ETHANOL 
ADMINISTRATION IN RATS FED NS AND CS DIETS FOR TEN DAYS1 •2 
Camitine 
Fraction · Groups 
(nmoles/ml) NS cs NSE CSE 
NEC 20.33 ± 1 .65. 39.76 ± 0.55b 24.82 ± 0.97· 43.06 ± 4. 19b 
ASAC 8.07 ± 1 .70- 7.58 ± 1 .41• 3.14 ± 0.64b 1 1 .64 ± 1 .36· 
AIAC 2.81  ± 1 . 10• 6.30 ± 1 .39• 3.25 ± 0.36· 5.48 ± 0.59· 
Total 3 1 .81  ± 4.45• 53.44 ± 3.35b 3 1 .21 ± 1 .97• 60. 18 ± 6. 14b 
1 .  All values are group means ± SEM (n=3 for NS and CS groups, n=5 for NSE and 
CSE groups). Those bearing the same superscript within a row are not 
significantly different (p > 0.05). 
NS = Nonsupplemented, CS = L-camitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-camitine supplemented + ethanol 
2. All NEC & ASAC values should be multiplied by a factor of 2 
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TABLE 19 
LIVER CARNITINE CONCENTRATIONS WITH AND WITHOUT ETHANOL 
ADMINISTRATION IN RATS FED NS AND CS DIETS FOR TEN DAYS 1 •2 
Carnitine 
Fraction 
(nmoles/g) 
NEC 
ASAC 
AIAC 
Total 
NS cs 
Groups 
NSE 
154.31 ± 24.83. 163.40 ± 10.18· 197.25 ± 16.56. 
74.60 ± 36.7ga 77.60 ± 12.94· 58.05 ± 18.73· 
2.92 ± 0.33• 3.12 ± 1.20- 7.29 ± 1.30b 
231.83 ± 61.958 244.12 ± 24.32• 262.59 ± 36.068 
CSE 
144.95 ± 16.56a 
78.43 ± 16.78a 
12.16 ± 1.61 b 
235 .54 ± 34.95a 
1. All values are group means ± SEM (n=3 for NS and CS groups, n=5 for NSE and 
CSE groups). Those bearing the same superscript within a row are not 
significantly different 
(p > 0.05). 
NS = Nonsupplemented, CS = L-carnitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-carnitine supplemented + ethanol 
2. All NEC and ASAC values should be multiplied by a factor of 2 
TABLE 20 
PLASMA AND LIVER TOT AL LIPIDS WITH AND WITHOUT ETHANOL 
ADMINISTRATION IN RATS FED NS AND CS DIETS FOR TEN DAYS 1 
Tissue NS cs 
Groups 
NSE CSE 
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Plasma 285.96 ± 39.98• 264. 10 ± 21 .28• 254.01 ± 15.92• 254.90 ± 20.01 a 
(mg Lipid/di) 
Liver 32. 16 ± 1 .73• 29.46 ± 0.57• . 30.58 ± 1 .61• 32.72 ± 1 .371 
(mg Lipid/g) 
1. All values are group means ± SEM (n=3 for NS and CS groups, n=5 .for NSE and 
CSE groups). Those bearing the same superscript within a row are not 
significantly different 
(p > 0.05. 
NS = Nonsupplemented, CS = L-carnitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-carnitine supplemented + ethanol 
TABLE 21 
PLASMA AND LIVER TRIGLYCERIDES WI1H AND WITHOUT ETHANOL 
ADMINISTRATION IN RATS FED NS AND CS DIETS FOR TEN DAYS 1 
0roU1!S 
Tissue NS cs NSE CSE 
Plasma 77.90 ± 1 .12· 80.01 ± 0.84. 7 4.03 ± 6.20· 75.90 ± 5 .84a 
(mg Lipid/di) 
Liver 1.78 ± 0.09· 1.96 ± 0.12· 5.20 ± 0.27b 5.37 ± 0.64b 
(mg Triglyceride/g) 
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1. All values are group means ± SEM (n=3 for NS and CS groups, n=5 for NSE and 
CSE groups). Those bearing the same superscript within a row are not 
significantly different 
(p > 0.05 . 
NS = Nonsupplemented, CS = L-carnitine supplemented 
NSE = Nonsupplemented + ethanol, CSE = L-carnitine supplemented + ethanol 
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In summary, ethanol administration resulted in decreased palmitate oxidation, but 
dietary camitine supplementation did not affect palmitate oxidation with or without 
ethanol admfnistration (Table 17). Camitine supplementation significantly increased 
NEC levels but did not change ASAC and AIAC concentration in the plasma (Table 
18). Liver AIAC concentrations were elevated by ethanol administration but not 
affected by carnitine supplementation. Liver NEC and ASAC levels were not changed 
by either carnitine supplementation or ethanol administration (Table 19). Ethanol 
administration also resulted in elevated triglyceride concentrations in the liver (Table 
2 1). 
CHAPTER V 
DISCUSSION 
Experiment 1 [l-14C]-Ethanol Oxidation 
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The oxidation of [l-14C]-ethanol to 14C02 was reduced by feeding the 0.5% L­
carnitine diet for seven days (fable 1 ). This could offer a partial explanation for the 
earlier observations of elevated blood-ethanol concentrations following carnitine 
supplementation (14, 1.5). It would be expected that blood and . hepatocyte ethanol 
should be at an equilibrium. Ethanol oxidation within the hepatocyte would result in 
an influx of ethanol from the blood in order to maintain the equilibrium. The entry of 
ethanol into the hepatocyte would lower blood-ethanol concentrations. So, by 
reducing ethanol oxidation there should be an increase in blood-ethanol concentrations. 
This point has been demonstrated in several studies involving the use of ethanol 
oxidation inhibitors (73-76). 
In the earlier studies (14, 1 5), carnitine supplementation resulted in at least a 30% 
increase in blood-ethanol concentratio_ns at hours 1 through 6. When ethanol oxidation 
was expressed as a perce�tage of the total dose expired as 14C02, it was possible to 
show a �inear difference between the NS and CS groups (Table 1 ). At one h the 
difference is only 0.5% but by 12h the difference is 10%. There seems to be a 
discrepancy between ethanol oxidation to CO2 and blood-ethanol concentrations (i.e. 
there is only a 2% reduction in ethanol oxidation to CO2 at 3h but a 30% increase in 
blood-ethanol concentrations). The explanation probably lies in the accumulation of 
acetate following ethanol administration. Oxidation of ethanol to acetate will lower 
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blood-ethanol concentrations, but the acetate is not oxidized to CO2 immediately, since 
the majority of ethanol is recovered in the blood as free acetate (39, 97). This is 
evident 8h after ethanol because administration by 8h blood-ethanol concentrations 
have almost returned to zero, but only a 45% (NS) and 39% (CS) of the ethanol dose 
has been oxidized to CO2• As the excess reducing equivalents generated from ethanol 
are depleted, acetate is then oxidized to CO2 and by 12 hr 85% (NS) and 75% (CS) of 
the total dose has been oxidized to CO2• 
By determining the amount of the 14C-label remaining in the body or excreted in 
the urine it was possible to assess the fate of ethanol not expired as CO2• Urinary 
excretion of [ l -14C]-ethanol or its metabolites was not significantly effected by 
carnitine supplementation and represented only 3% of the total dose (Table 2) . It 
should be noted that evaporation or decomposition of components in the urine may 
have resulted in an underestimation in urinary excretion of the label. Tissue 
distribution of the 14C-label was also not significantly affected by carnitine 
supplementation (Table 3). 
Experiment 2 . Blood and Liver Ethanol Concentrations and Redox State 
Dietary carnitine supplementation for 7d resulted in a 30% increase in blood­
ethanol concentrations 3h after ethanol administration (Table 4) which is comparable 
to earlier �ata (14, 15). At the same time liver-ethanol concentrations were twice as 
high in the NS group compared to CS rats (Table 4 ). In contrast, it would be 
expected that the number of DPM would be higher in the NS liver due to elevated 
ethanol concentrations, hut there is no significant difference in the number of DPM 
. . 
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between the two groups (Table 4 ). The CS group would also be expected to have a 
higher number of DPM in the plasma, but there were no significant differences in 
plasma DPM between the NS and CS groups (Table 4 ). 
One possible mechanism to explain the above situation is that carnitine could be 
inhibiting the entry of ethanol into the hepatocyte. This would explain the increased 
blood and decreased liver concentrations of ethanol in the CS group. The lower 
concentration of ethanol in the hepatocyte would present less of a "redox burden" ort 
the liver and result in quicker oxidation of ethanol to acetaldehyde and acetate. 
Acetate would then accumulate within the hepatocyte because of the inhib�tion of the 
TCA cycle by ethanol (49). Normally most of the acetate would be activated to 
acetyl-CoA and transported out of the mitochondrial matrix as citrate and appear in the 
blood as free acetate (39, 19). However, Brass and Hoppel have shown that 
exogenous carnitine increased acetyl-carnitine concentrations in the liver and the effect 
was greater when the rats were starved (i.e. high acetate levels) and suggested that the 
hepatic acetyl-carnitine pool reflects changes in the hepatic acetyl-CoA pool (99). 
Table 7 clearly shows the increase in NEC, ASAC, and AIAC concentrations in the 
liver of CS rats. Thus, it is probable that the acetate formed from ethanol is being 
esterified to carnitine and remaining in the hepatocyte rather than entering the blood as 
free acetate. This would explain why there are lower liver-ethanol concentrations but 
no difference in the number of DPM in the CS group. In short, in NS rats the 
ethanoVmetabolite ratio would be higher in the liver and lower in the blood th.an in CS 
rats. 
90 
It was originally suspected that carnitine supplementation was increasing B-
oxidation resulting in a more reduced state in the liver which would inhibit ethanol 
oxidation. However, the data from the above experiment would suggest that carnitine 
supplementation might result in a more oxidized state in the CS liver due to lower 
ethanol concentrations in the liver. Examination of liver revealed no significant 
differences in pyruvate, lactate, 3-hydroxybutyrate and acetoacetate between the NS 
and CS groups (Table 5). In both groups there were decreased liver concentrations of 
pyruvate and acetoacetate and increased concentrations of lactate and 3-
hydroxybutyrate. The shift in redox pairs to a more reduced state is characteristic of 
etha�ol metabolism and is the major metabolic consequence of ethanol oxidation (10, 
· 11, 94). 
Ethanol administration caused nearly a 3-fold decrease in plasma pyruvate 
concentrations, but there were no significant differences between the NS and CS 
groups (Table 6). Plasma lactate concentrations were increased by ethanol 
administration. Moreover, CS rats had almost a 2-fold increase in plasma lactate 
compared to NS rats. Himwich, et al (95) stated that ethanol acts as a glycogenolytic 
agent in the muscle and the glycogen is oxidized to lactate in the muscle and released 
into the blood. However, the role of carnitine in this process is not clear at this point 
in time. Plasma 3-hydroxybutyrate concentrations and 3-hydroxybutyrate/acetoacetate 
were elevated by ethanol administration but not significantly affected by carnitine 
supplementation (Table 6). 
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Earlier studies in this laboratory have demonstrated that plasma NEC 
concentrations are elevated by carnitine supplemen�tion (for 7 days) without ethanol 
administration (1 5,77) and after 45 days on a liquid ethanol diet containing 36% of the 
calories as ethanol (13) .  However, in these studies plasma ASAC and AIAC fractions 
were not significantly increased. In this experiment all three plasma camitine fractions 
were about 2-fold higher in the CS group 3h after ethanol administration (Table 7). 
Dietary carnitine supplementation (0.5% w/w) for 6 wk resulted in increased liver 
NEC but failed to increase ASAC & AIAC concentrations (96). But after 45d of the 
liquid ethanol diet NEC, ASAC, and AIAC concentrations were elevated in the CS 
group (13). Kondrup and Grunett (99) found that a single dose of ethanol had no 
effect of liver CoA content, but acetyl-CoA, acetylcarnitine and free camitine 
concentrations were increased and concentrations of long-chain acyl-CoA and long-
. chain acylcarnitines were decreased. In this study NEC, ASAC and AIAC content of 
the liver were significantly higher in the CS group (Table 7). Ethanol administration . . 
results in an . increased �ount of acyl groups in the liver. Short-chain acyl groups are 
probably in the form of acetate which would be the result of ethanol oxidation. Long­
chain acyl groups are probably the result of mobilization from adipose tissue through 
the action of ethanol on lipases ( 1). Increasing the concentrations of NEC in the liver 
through dietary carnitine supplementation should favor the formation of acyl­
carnitines. In short, ethanol is increasing one subs�ate (acyl groups) and 
supplementation is increasing the other substrate (carnitine) for carnitine acyl 
transferases which results in increased concentrations of the product (acyl carnitines) 
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(Table 7). Three hours after an acute dose of ethanol all three carnitine fractions were , 
higher in the CS group (Table 7). Liver carnitine concentrations have been shown not 
to be altered,by carnitine supplementation without ethanol administration (96), but 
after 45 days on the liquid ethanol diet NEC, ASAC, and AIAC concentrations were 
elevated in the CS groups ( 13). Three hour� after an acute dose of ethanol all three 
camitine fractions were higher in the CS group (Table 7). 
Experiment 3 Urinary Excretion of [1-14C]-Ethanol 
Carnitine is known to enhance the excretion of organic acids associated with 
metabolic disorders' such as methylmalonic and propionic aciduria (89-91). Ethanol 
oxidation cre�tes an abu�dance of acetate in the liver and blood. Ethanol also causes 
an influx of fatty acids into the liver. Fatty acids have the potential to become 
esterified to camitine and excreted in the urine. Therefore, it was decided to 
determine if carnitine supplementation would increase the excretion of acyl-camitines 
following ethanol administration. 
Urinary volume was not significantly affected by carnitine supplementation for 
24h following ethanol administration (Table 8, Figure 12). The largest volume was 
excreted in the first 3h following ethanol administration. This volume is 
approximately equal to the volume of the gavage. For the next 9h urine volume drops 
sharply followed by an increase over the next twelve hours. Food and water intakes 
were not significantly different between the NS and CS groups (Table 8). 
Twenty four hour excretion of ethanol in the urine was not significantly different 
between the NS and CS groups (Table 9, Figure 12). The highest amount of ethanol 
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in the urine was for the first 3h with the NS group excreting 77% of the total 24h 
ethanol and the CS group excreting 84%. Ethanol excretion declined steadily for the 
next 21 h. This coincides with blood-ethanol concentrations peaking at three hours and 
sharply declining to near zero by 8h. 
The total amount of radioactivity excreted over the 24h period was not 
significantly affected by carnitine supplementation (Table 9, Figure 12). The greatest 
amount was excreted in the first three hours. Over the next 3h there was a sharp drop 
in radioactivity; followed by an increase from 6 to 12 h. In the final 12h only a small 
amount of the 14C-label is excreted. 
A possible scenario to explain the above situation is as follows. The gavage 
results in a large increase in blood volume and blood-ethanol concentrations. The 
body reacts by_ increasing urinary ex�retion and ethanol is excreted along with water. 
This would account for the increased urine volume, total ethanol and DPM for the first 
3h. Over the next 3h urine output drops sharply and blood-ethanol concentrations 
decline; explaining decreased total ethanol and DPM. From 6 to 12 h blood-ethanol 
concentrations virtually disappear, the amount of ethanol in the urine drops, but 
radioactivity in the urine rises sharply. It would seem reasonable to assume that the 
ethanol has been metabolized to acetate by the liver, transported out of the 
mitochondria, into the blood and excreted in the urine. By 12h hours most of the 
acetate derived from ethanol has been further oxidized to CO2 or excreted in the urine 
and the radioactivity in the urine drops. 
Urinary excretion of NEC, ASAC, and AIAC is dramatically increased by 
carnitine supplementation (Table 10, 1 1  ). The high NEC values in the urine are 
expected since excess camitine is excreted in the urine unchanged. Of particular 
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interest are the ASAC and AIAC fractions. In the f1:fSt 3h following the ethanol 
gavage there is a 60 fold increase in ASAC and a 27 fold increase in AIAC in the CS 
group. The total ASAC and AIAC is 4,706 nmoles. During this same time period 
there were no significant differences in ethanol excretion or total DPM (Table 9). In 
other words, the increases in ASAC and AIAC are not reflected in DPM or ethanol 
excretion. Over the next 3h total ASAC and AIAC drops to 3 15 nmoles, but there 
still is a 13-fold increase in ASAC and a 46-fold increase in AIAC in the CS group. 
From 6 to 12 h there is a slight increase (=100 nmoles) in total ASAC and AIAC. 
However, the number of DPM in the urine increases dramatically (Table 19). The 
largest amount of total ASAC and AIAC, 8957 nmoles, are excreted from twelve to 
twenty four hours. There is an 80-fold increase in ASAC and a 41-fold increase in 
AIAC in the CS group. These increases are not reflected in DPM excreted which 
actually drop (Table 9). 
Originally it was presumed that the excess acetate generated from ethanol 
oxidation would be esterified to carnitine and excreted in the urine. This was 
observed in humans given IV carnitine after drinking wine ( 61 ). It is definitely clear 
that the ex�tion of both short and long chain acyl-carnitines is enhanced by carnitine 
supplementation, but it is not clear if the acyl-units are derived from ethanol. . The 
number of DPM would be expected to increase and follow the same pattern of . 
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excretion as ASAC and .AIAC if the acyl-units were derived from ethanol, but there 
are no significant differences in DPM between the NS and CS groups. Furthermore, 
DPM peaked'from 0-3 hrs and 6-12 hrs. while carnitine peaked from 0-3 hr and 12-24 
hr. So, it appears that the acyl-units being excreted in the urine are not entirely 
derived from ethanol. 
Experiment 4 {14C(U)J - Palmitate Oxidation Time Course 
A number of early in vitro studies demonstrated that the addition of carnitine to 
preparations of rat liver slices (78 ), isolated mitochondria (79), hepatocytes (80) or the 
pe�u�ing media of livers (8 1) could stimulate fatty acid oxidation and ketogenesis. 
However, the conclusions of several (82-87) in vivo studies were contradictory with 
regards to the stimulation of fatty acid oxidation and were performed under a variety 
of conditions. One of the original theories for elevated blood-ethanol concentrations 
and the decrease in hepatic steatosis was that dietary carnitine supplementation is able 
to stimulate fatty acid oxidation. Therefore, it was decided to determine if fatty acid 
oxidation· was stimulated by dietary carnitine supplementation in rats under control 
conditions. Dietary camitine supplementation over a 40d period did not significantly 
affect the oxidation of [14C(µ)]-palmitate to 14C02 over a 24h period (Table 12). The 
amount of palmitate oxidized to CO2 in 24h was only 25% of the total dose; compared 
to ethanol where 80% of the dose was oxidi7.ed to CO2 in 12h. This demonstrates the 
urgency that the body places on the metabolism of ethanol compared to a natural 
dietary component. 
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Camitine supplementation for ten days resulted in significantly higher plasma NEC 
and unchanged ASAC and AIAC (Table 13). Which is in agreement with earlier data 
(15, 77), but contrasts with the elevated ASAC and AIAC concentrations seen three 
hours after ethanol (Table 7). Camitine supplementation for forty days resulted in 
significantly higher plasma NEC and AIAC concentrations. ASAC concentrations 
were ahpost doubled in the CS group, but not significantly different. It appears that 
long term camitine supplementation has an inductive effect on the synthesis of acyl-
carnitines. 
Examination of liver camitine revealed no significant differences in the NEC, 
ASAC, and AIAC fractions between the NS and CS groups after ten days of feeding 
the CS diet (Table 14). There was a substantial increase in NEC, ASAC and AIAC 
concentrations in the 40d livers. However, the increase was not significant because of 
large standard deviation. This may prove to be significant if larger numbers of rats 
are used. It should also be pointed out the plasma increases in the NEC fraction are 
not present in the liver after ten days, but after forty days liver camitine content is 
reflecting plasma carnitine values in terms of % NS/CS. 
Plasma and liver total lipids and triglycerides were not significantly different 
between the NS and CS groups at 10 or 40 d of camitine supplementation (Tables 15 ,  
16). No decrease would be expected since there were no differences in palmitate 
oxidation. 
Experiment 5 [14C(U)]Palmitate Oxidation with Ethanol 
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The inhibition of fatty acid oxidation by ·ethanol administration is one of the 
primary causes of hepatic steatosis ( 46-49). It was originally speculated that carnitine 
supplementation would partially prevent the decrease in fatty acid oxidation by 
ethanol. Experiment IV, Table 12, demonstrated that carnitine supplementation did not 
stimulate fatty acid oxidation under normal circumstances, but it was not cl�ar whether 
or not carnitine supplementation would help alleviate the acyl burden imposed upon 
the liver by ethanol. 
Ethanol was orally administered two hours after a [14C(U)]-palmitate gavage. The 
oxidation of palmitate to CO2 was significantly reduced for the next twenty two hours 
(Table 17, Figure 13). However, carnitine supplementation did not significantly affect 
14C02 expiration with or without ethanol. On the average there was about a 50% 
reduction in palmitate oxidation with ethanol treatment 
As demonstrated earlier ( 13, 15, 77, 96), there was an increase in NEC 
concentrations in plasma in the CS and CSE groups, but ethanol administration did not 
significantly change NEC concentrations (Table 18). AIAC concentrations were 
significantly reduced in the NS group which may indicate an increased need for 
carnitine (that can't be met by endogenous synthesis or the chow diet) following 
ethanol administration. There were no significant differences in AIAC concentrations 
between the NS, CS, NSE, and CSE groups. Thus the increased plasma carnitine 
values observed in the CS group at three hours after ethanol administration (Table 7) 
have returned to the pre-ethanol status (pattern) after 24h. 
There were no significant differences in liver NEC and ASAC concentrations 
between the NS, CS, NSE and CSE groups (Table 19). AIAC concentrations were 
significantly higher in the NSE and CSE groups, but carnitine supplementation did 
significantly change AIAC concentrations. The increased AIAC concentration is 
probably the result of increased concentrations of long chain fatty acids available for 
esterification to carnitine. Again, the increased NEC, ASAC, and AIAC 
concentrations observed three hours (Table 7) after ethanol administration are not 
evident at twenty four hours. 
98 
Unlike what occurs with chronic ethanol administration (12, 13) plasma and liver 
total lipids were not significantly increased by a single acute . close of ethanol in the 
NS, CS, NSE, and CSE groups (Table 20). The acute dose did increase liver 
triglycerides, but the increase was not affected by carnitine. Plasma triglycerides were 
not significantly different between the NS, CS, NSE, and CSE groups (Table 21) . 
CHAPTER VI 
SUMMARY 
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The purpose of this dissertation was to explore the potential mechanisms by which 
dietary camitine supplementation causes elevated blood-ethanol concentrations and 
decreased hepatic lipids following ethanol administration. The hypothesis was that 
dietary camitine supplementation would result in higher than normal concentrations of 
camitine and acyl-camitines and alter the oxidation of ethanol and its metabolic 
consequences. Ethanol administration results in an increase in the hepatic pool of 
acyl-CoA's. Two fates of hepatic acyl-CoA's is esterification to glycerol or camitine. 
Esterification to glycerol would lead to the storage of the acyl groups as triglycerides 
and cause hepatic steatosis. Esterification to carnitine would lead to an increase in the 
oxidation of the acyl groups or their transport out of the hepatocyte since acyl-CoA is 
impermeable to cell membranes. By increasing the availability of camitine, through 
dietary camitine supplementation, it seemed possible to increase the quantity of acyl 
moities being esterified to camitine. The excess camitine would also be available for 
esterification to the excess acetylmoities generated from ethanol oxidation. Thus, by 
binding Acyl and Acetyl moities, camitine would be shuttling these groups away from 
their normal routes following ethanol oxidation. 
The effect of carnitine supplementation on ethanol oxidation was examined by 
feeding rats purina chow as such (non-supplemented, NS) or supplemented with 0.5% 
L-carnitine (camitine supplemented, CS) for. 7d. The rats were then given an .oral 
dose of [ 1 - 14C]-ethanol and placed in respiratory chambers. Expired 14C02 was 
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collected for the next 12h at which time the rats were killed. Ethanol oxidation to 
14C02 was significantly reduced at hours 4- 12 in the CS group. At the end of 12h the 
NS group had expired 85% of the �tal dose as CO2 and the CS group 75_%. There . · 
were no significant differences in urinary excretion of the 14C-label between the two 
groups which accounted for only about 3% of the total dose. The 14C-label remaining 
in tissues after 12h was also not significantly affected by carnitine supplementation. 
Thus a partial explanation for carnitine supplementation resulting in increased blood­
ethanol concentrations is a reduction in ethanol oxidation. The effect of carnitine 
supplementation on blood and liver-ethanol concentrations and the redox state was 
examined by feeding the rats NS and CS diets for 7d. The rats were then given an 
oral dose of [1- 14C]-ethanol and killed 3h later. Blood-ethanol concentrations were 
88.5 mg/di in the NS group and 125.9 mg/di in the CS group at 3h. Liver-ethanol 
concentrations were 1 .  70 pg/mg in the NS group and 0.85 pg/mg in the CS group. 
However, there were no significant differences in the number of DPM in the plasma or 
liver between the two groups. Measurement of liver concentrations of pyruvate, 
lactate, acetoacetate, and 3-hydroxybutyrate revealed no significant differences 
between the NS and CS groups. Plasma concentrations of lactate were 2-fold higher 
in the CS group, but pyruvate, acetoacetate and 3-hydroxybutyrate concentrations were 
not significantly different between the two groups. Plasma and liver non-esterified 
carnitine (NEC), acid soluble acylcarnitine (ASAC) and acid insoluble acylcarnitine 
(AIAC) concentration� were all significantly higher in the CS group 3h after ethanol 
administration which would support the hypothesis of increased acyl-carnitines after 
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ethanol administration. It is concluded that dietary carnitine supplementation results in 
increased blood-ethanol concentrations and decreased liver-ethanol concentrations 
possibly by inhibiti�g the entry of ethanol into the hepatocyte. Additionally, carnitine 
supplementation had no effect on the redox state of the ljver but may effect muscle 
metabolism due to elevated plasma lactate concentration. Finally, both of the above 
effects may be related to the elevated �arnitine concentrations observed in the CS 
group. 
The effect of carnitine supplementation on the urinary excretion of ethanol, its 
metabolites and carnitine was determined by feeding rats the NS and CS diets for 7d. 
The rats were then given an oral dose of [1-14C]-ethanol and urine was collected for 
the next 24h. Food intake, water intake and urine volume were not significantly 
different between the NS & CS groups over the 24h period. Urinary excretion of 
ethanol and the 14C-label were not significantly affected by carnitine supplementation. 
Urinary excretion of NEC, ASAC, and AIAC was dramatically increased by carnitine . -
supplementation. From �3h there was a 165, a 60, and a 27-fold increase in NEC, 
ASA� & AIAC, respectively in the CS group. From 3-6h there was a 100, a 13, and 
a 46-fold increase in NEC, ASAC & AIAC, respectively in the CS group. From 6-
12h there was a 40, a 5� and a 20-fold increase in NEC, ASAC & AIAC, respectively 
in the CS group. From 12-24h there was a 40-fold (NEC), a 80-fold (ASAC), and a 
40-fold (AIAC) increase in the CS group. It is co�cluded that dietary carnitary 
supplementation enhances the excretion of acyl groups in the urine following ethanol 
administration without increasing excretion of ethanol or its metabolites. The effects 
of supplementary camitine on the oxidation of palmitate was determined by feeding 
the NS and CS diets for 5, 10, 20, 30, and 40 days. A single oral dose of [14C(U)]-
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palmitate was given and the rats were placed in a respiratory chamber. Expired CO2 
was trapped in KOH solution which was counted to determine amount of radioactivity 
at 4, 8, 12  & 24 h post-gavage. There were no significant differences between the NS 
and CS groups with regard to the rates of 14C02 appearance or percent of the dose 
following 5, 10, 20, 30 & 40 days of feeding CS di�t. Because there were no 
significant differences in palmitate oxidation over the 40d period. 10d and 40d were 
chosen to represent short and long term camitine supplementation. Plasma NEC 
conce_ntrations were significantly higher in the CS group after 10d of supplementation, 
but ASAC and AIAC concentrations were not affected. After 40d of supplementation 
plasma NEC and AIAC concentrations were significantly higher in the CS group and 
ASAC concentrations were doubled in the CS group but not statistically significant. 
There were no significant differences between the NS and CS groups in liver 
concentrations of NEC, ASAC, and AIAC at 10 and 40d. However, 40d was superior 
to 10d in elevating NEC, ASAC, and AIAC in the liver. Analyses of plasma and liver 
of NS and CS rats revealed no significant differences in total lipids or triglycerides. It 
is concluded th_at in the intact rat, 0.5% L-camitine supplementation did not 
significantly alter oxidation of orally administered palmitate to CO2• Additionally, 
supplementary carnitine was neither hypolipidemic nor lipotropic in normal rats fed 
Purina rat chow. 
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. The effect of camitine supplementation and ethanol administration on palmitate 
oxidation was determined by feeding rats NS and CS diets for 10d. They were then 
given an oral dose of [14C(U)]-palmitate followed by an oral dose of ethanol 2h later. 
Expired 14C02 was then collected for the next 24h then killed. Ethanol administration 
resulted in decreased palmitate oxidation, at hours 4-24, but dietary camitine 
supplementation did not affect palmitate oxidation with or without ethanol 
administration. Carnitine supplementation sigi:iificantly increased NEC levels but did 
not change ASAC and AIAC concentration in the plasma. Liver AIAC concentrations 
were elevated by ethanol administration but not affected by camitine supplementation. 
Liver NEC and ASAC levels, which were elevated 3h after ethanol administration, 
were not significantly different 24h after ethanol administration. Ethanol 
administration also resulted in elevated triglyceride concentrations in the liver, but 
liver total lipids were unchanged. Plas�a total lipids and trigly�eride concentrations 
were not significantly affected by ethanol administration and/or carnitine 
supplementation. It is concluded that ethanol administration reduced the amount of 
palmitate oxidized to CO2 over a 24h period, but dietary camitine supplementation did 
not prevent' the ethanol-induced decrease in palmitate oxidation. 
In summary, dietary camitine supplementation has the following effects on ethanol 
and palmitate metabolism: 
1) It decreases the oxidation of ethanol to CO2 without affecting the redox state of 
the liver. 
2) It results in higher blood-ethanol and lower liver-ethanol concentrations. 
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3) It results in a tremendous increase in the urinary excretion of both short and long 
chain acyl groups following ethanol administration. 
4) It does not affect the oxidation of palmitate to CO2 with or without ethanol 
. administration. 
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